Breaking News

Tuesday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Recommendations	Azenta price target lowered to $94 from $106 at B. Riley » 07:42 05/17/22 05/17 07:42 05/17/22 07:42 AZTA Azenta $74.56 / -0.485 (-0.65%) B. Riley analyst Yuan Zhi… B. Riley analyst Yuan Zhi lowered the firm's price target on Azenta to $94 from $106 and keeps a Buy rating on the shares. The recent stock movement in the healthcare service an technology sector and the trading volume in the past week gives confidence in the "bottom-forming of these growth-oriented stocks," Zhi tells investors in a research note. The analyst remains a buyer of the life sciences services providers that maintain "strong growth." ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options AZTA Azenta $74.56 / -0.485 (-0.65%) 01/06/22 Azenta names Matthew McManus as COO AZTA Azenta $74.56 / -0.485 (-0.65%) 05/10/22 Needham Azenta price target lowered to $94 from $115 at Needham 03/31/22 B. Riley Azenta resumed with a Buy at B. Riley 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham AZTA Azenta $74.56 / -0.485 (-0.65%) 05/09/22 Azenta sees Q3 adjusted EPS 9c-17c, consensus 18c 05/09/22 Azenta reports Q2 preliminary adjusted EPS 12c, consensus 11c 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AZTA Azenta $74.56 / -0.485 (-0.65%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations AZTA Azenta $74.56 / -0.485 (-0.65%) 12/01/21 Thirteen new option listings and one option delisting on December 1st

Over a week ago
Recommendations	Azenta price target lowered to $94 from $115 at Needham » 09:13 05/10/22 05/10 09:13 05/10/22 09:13 AZTA Azenta $64.69 / -6.35 (-8.94%) Needham analyst David… Needham analyst David Saxon lowered the firm's price target on Azenta to $94 from $115 to reflect peer multiple contraction but keeps a Buy rating on the shares. M&A is the likely next catalyst for the company, though he expects Azenta's organic underlying strength to continue as COVID-related headwinds ease, the analyst tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AZTA Azenta $64.69 / -6.35 (-8.94%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AZTA Azenta $64.69 / -6.35 (-8.94%) 03/31/22 B. Riley Azenta resumed with a Buy at B. Riley 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel AZTA Azenta $64.69 / -6.35 (-8.94%) 05/09/22 Azenta sees Q3 adjusted EPS 9c-17c, consensus 18c 05/09/22 Azenta reports Q2 preliminary adjusted EPS 12c, consensus 11c 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AZTA Azenta $64.69 / -6.35 (-8.94%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/10/22 Healthcare Conference AZTA Azenta $64.69 / -6.35 (-8.94%) 12/01/21 Thirteen new option listings and one option delisting on December 1st
Earnings	Azenta sees Q3 adjusted EPS 9c-17c, consensus 18c » 16:35 05/09/22 05/09 16:35 05/09/22 16:35 AZTA Azenta $64.69 / -6.35 (-8.94%) Sees Q3 revenue… Sees Q3 revenue $140M-$150M, consensus $150.38M. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AZTA Azenta $64.69 / -6.35 (-8.94%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AZTA Azenta $64.69 / -6.35 (-8.94%) 03/31/22 B. Riley Azenta resumed with a Buy at B. Riley 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel AZTA Azenta $64.69 / -6.35 (-8.94%) 05/09/22 Azenta reports Q2 preliminary adjusted EPS 12c, consensus 11c 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AZTA Azenta $64.69 / -6.35 (-8.94%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/10/22 Healthcare Conference 05/09/22 Azenta - AZTA AZTA Azenta $64.69 / -6.35 (-8.94%) 12/01/21 Thirteen new option listings and one option delisting on December 1st
Earnings	Azenta reports Q2 preliminary adjusted EPS 12c, consensus 11c » 16:34 05/09/22 05/09 16:34 05/09/22 16:34 AZTA Azenta $64.69 / -6.35 (-8.94%) Reports Q2 preliminary… Reports Q2 preliminary revenue $146M, consensus $142.1M. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AZTA Azenta $64.69 / -6.35 (-8.94%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AZTA Azenta $64.69 / -6.35 (-8.94%) 03/31/22 B. Riley Azenta resumed with a Buy at B. Riley 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel AZTA Azenta $64.69 / -6.35 (-8.94%) 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AZTA Azenta $64.69 / -6.35 (-8.94%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/10/22 Healthcare Conference 05/09/22 Azenta - AZTA AZTA Azenta $64.69 / -6.35 (-8.94%) 12/01/21 Thirteen new option listings and one option delisting on December 1st

Over a month ago
Initiation	Azenta resumed with a Buy at B. Riley » 08:16 03/31/22 03/31 08:16 03/31/22 08:16 AZTA Azenta $86.03 / -2.34 (-2.65%) B. Riley analyst Yuan Zhi… B. Riley analyst Yuan Zhi resumed coverage of Azenta with a Buy rating and $106 price target. The company is a global leader of cold-chain sample management solutions and genomics service providers, Zhi tells investors in a research note. The analyst says Azenta has built leading capabilities of genomics, cryostorage, automation, and informatics to accelerate drug discovery and delivery. Zhi models 2022 revenue growth of 15%, with a gross margin of 49% and adjusted EBITDA of $113M. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AZTA Azenta $86.03 / -2.34 (-2.65%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AZTA Azenta $86.03 / -2.34 (-2.65%) 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel 11/17/21 Stephens Brooks Automation price target raised to $137 from $130 at Stephens AZTA Azenta $86.03 / -2.34 (-2.65%) 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AZTA Azenta $86.03 / -2.34 (-2.65%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/07/22 Disruptive Biotech Enabling Technologies Virtual Mini Conference AZTA Azenta $86.03 / -2.34 (-2.65%) 12/01/21 Thirteen new option listings and one option delisting on December 1st

Conference/Events	KeyBanc to hold a virtual forum » 04:55 03/23/22 03/23 04:55 03/23/22 04:55 AGTI Agiliti $20.24 / +0.41 (+2.07%) , AMWL Amwell $3.97 / +0.145 (+3.80%) , ANGO AngioDynamics $22.71 / -0.44 (-1.90%) , AVNS Avanos $32.46 / +0.51 (+1.60%) , AVTR Avantor $34.73 / +0.245 (+0.71%) , AZTA Azenta $86.72 / +0.19 (+0.22%) , BLFS BioLife Solutions $23.18 / +0.335 (+1.47%) , CSTL Castle Biosciences $45.89 / +2.68 (+6.20%) , EBS Emergent BioSolutions $42.52 / +1.03 (+2.48%) , ENZ Enzo Biochem $3.04 / +0.04 (+1.33%) , EVH Evolent Health $31.91 / +0.55 (+1.75%) , ICUI ICU Medical $242.89 / -4.85 (-1.96%) , INGN Inogen $33.31 / +0.1 (+0.30%) , IVC Invacare $1.60 / +0.01 (+0.63%) , LMAT LeMaitre $45.32 / +1.54 (+3.52%) , MRVI Maravai Lifesciences $38.84 / +0.34 (+0.88%) , NXGN NextGen Healthcare $20.31 / +0.15 (+0.74%) , PINC Premier $35.90 / +0.07 (+0.20%) , TFX Teleflex $346.65 / -0.61 (-0.18%) , WST West Pharmaceutical $413.43 / +0.93 (+0.23%) , XGN Exagen $8.25 / +0.21 (+2.61%) Life Sciences &… Life Sciences & MedTech Virtual Forum to be held on March 22-23. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XGN WST TFX PINC NXGN MRVI LMAT IVC INGN EVH ENZ EBS CSTL BLFS AZTA AVTR AVNS ANGO XGN Exagen $8.25 / +0.21 (+2.61%) 03/22/22 Exagen receives subpoena in Feb. from DOJ, says 'fully cooperating' 10/27/21 Exagen expands coverage with Inland Empire Health Plan 10/25/21 Exagen announces $27.2M debt refinancing WST West Pharmaceutical $413.43 / +0.93 (+0.23%) 02/28/22 West Pharmaceutical names Eric Green as Chair of Board 01/25/22 West Pharmaceutical enters supply, technology agreement with Corning TFX Teleflex $346.65 / -0.61 (-0.18%) 02/23/22 Teleflex: FDA clears expanded indication for specialty catheters PINC Premier $35.90 / +0.07 (+0.20%) 03/14/22 Sodexo announces national GPO agreement with Premier 10/26/21 Premier, Resilinc announce supply chain transparency collaboration NXGN NextGen Healthcare $20.31 / +0.15 (+0.74%) 12/15/21 NextGen Healthcare CMO Betty Rabinowitz to retire, Robert Murry to succeed 10/28/21 NextGen Healthcare announces $60M share repurchase program 10/05/21 Proxy firms ISS and Glass Lewis support NextGen Healthcare director nominees 09/28/21 NextGen Healthcare provides presentation amid proxy fight against Sheldon Razin MRVI Maravai Lifesciences $38.84 / +0.34 (+0.88%) 02/25/22 Maravai Lifesciences up 10% after Reuters says rejected $42 per share bid 01/28/22 Maravai Lifesciences acquires MyChem for $240M in cash 12/14/21 Maravai Lifesciences added to the Nasdaq Biotechnology Index 11/29/21 Codex DNA announces commercial availability of BioXp mRNA synthesis kits LMAT LeMaitre $45.32 / +1.54 (+3.52%) 02/24/22 LeMaitre announces $20M share repurchase authorization IVC Invacare $1.60 / +0.01 (+0.63%) 03/08/22 Invacare sees FY22 adjusted EBITDA, free cash fow up from FY21 12/01/21 Invacare realigns EMEA, Asia Pacific businesses 11/30/21 FDA posts warning letter sent to Invacare on November 18 11/05/21 NetScout to replace Invacare in S&P 600 at open on 11/5 INGN Inogen $33.31 / +0.1 (+0.30%) 03/04/22 Inogen names Kristin Caltrider as CFO, succeeding Mike Sergesketter 02/24/22 Inogen sees Q1 revenue similar to Q4, sees FY22 revenue up mid-single digits 12/30/21 Inogen appoints Elizabeth Mora as board chairperson 12/13/21 Inogen announces Sergesketter as Interim Chief Financial Officer EVH Evolent Health $31.91 / +0.55 (+1.75%) 03/07/22 Evolent Health expects to continue provision of services to Cook County Health 02/24/22 Evolent Health rises 16.3% 10/15/21 Evolent Health up 2% as Dealreporter speculates on deal fit with Walgreens 09/29/21 Evolent Health trading resumes ENZ Enzo Biochem $3.04 / +0.04 (+1.33%) 01/03/22 Enzo Biochem appoints CEO Hamid Erfanian to board 10/25/21 Radoff issues letter to Enzo independent directors regarding shareholder unrest 10/21/21 Enzo Biochem expands GoTestMeNow online portal 10/18/21 Enzo Biochem appoints Hamid Erfanian as Chief Executive Officer EBS Emergent BioSolutions $42.52 / +1.03 (+2.48%) 03/11/22 Emergent BioSolutions initiates Phase 1 study of SIAN 02/18/22 FDA says added four lots of AstraZeneca COVID vaccine acceptable for export 02/11/22 Emergent BioSolutions 'disappointed' in appeals ruling in Narcan case with Teva 01/14/22 Emergent BioSolutions founder and executive chairman, Fuad El-Hibri, to retire CSTL Castle Biosciences $45.89 / +2.68 (+6.20%) 01/12/22 Castle Biosciences publishes sequencing panel study for melanoma analysis 11/24/21 Castle presents data backing clinical utility of DecisionDx portfolio 11/19/21 Castle Biosciences announces publication of DecisionDx-Melanoma data 10/25/21 Castle Biosciences acquiring Pittsburgh Life Science Greenhouse's Cernostics BLFS BioLife Solutions $23.18 / +0.335 (+1.47%) 03/18/22 BioLife Solutions receives Nasdaq notice of noncompliance for delayed 10-K 03/17/22 BioLife Solutions announces additional delay in filing Form 10-K 11/04/21 BioLife Solutions names Troy Wichterman as CFO, Roderick de Greef as COO AZTA Azenta $86.72 / +0.19 (+0.22%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AVTR Avantor $34.73 / +0.245 (+0.71%) 02/15/22 Avantor chairman Rajiv Gupta to retire 02/11/22 Avantor starts construction on new distribution center in Ireland 11/15/21 Third Point buys Alight, exits Uber in Q3 AVNS Avanos $32.46 / +0.51 (+1.60%) 12/15/21 Avanos announces $30M share repurchase program 12/13/21 Avanos to acquire OrthogenRx, Inc. for $160M ANGO AngioDynamics $22.71 / -0.44 (-1.90%) 01/12/22 AngioDynamics CEO buys $228K in common stock AGTI AMWL ANGO AVNS AVTR AZTA BLFS CSTL EBS ENZ EVH ICUI INGN IVC LMAT MRVI NXGN PINC TFX WST XGN AGTI Agiliti $20.24 / +0.41 (+2.07%) 03/09/22 Citi Agiliti price target lowered to $25 from $28 at Citi 01/10/22 Citi Agiliti assumed with a Buy at Citi 08/16/21 Citi Citi says Agiliti selloff overdone, boosts target to $22 05/26/21 BMO Capital Agiliti price target raised to $26 from $18 at BMO Capital AMWL Amwell $3.97 / +0.145 (+3.80%) 02/25/22 Piper Sandler Amwell price target lowered to $7 from $12 at Piper Sandler 02/11/22 Goldman Sachs Amwell initiated with a Neutral at Goldman Sachs 12/01/21 Jefferies Amwell initiated with a Hold at Jefferies 11/22/21 Piper Sandler Piper remains buyer of Amwell despite chat supporting below consensus FY22 view ANGO AngioDynamics $22.71 / -0.44 (-1.90%) 01/07/22 Canaccord AngioDynamics price target lowered to $34 from $37 at Canaccord 10/15/21 Fly Intel: Top five analyst upgrades 10/15/21 Canaccord AngioDynamics upgraded to Buy at Canaccord on future growth clarity 10/15/21 Canaccord AngioDynamics upgraded to Buy from Hold at Canaccord AVNS Avanos $32.46 / +0.51 (+1.60%) 02/24/22 KeyBanc Avanos price target lowered to $41 from $47 at KeyBanc 08/04/21 KeyBanc Avanos price target lowered to $47 from $55 at KeyBanc 08/04/21 Stephens Avanos downgraded to Equal Weight from Overweight at Stephens AVTR Avantor $34.73 / +0.245 (+0.71%) 02/07/22 Raymond James Avantor price target lowered to $43 from $47 at Raymond James 02/07/22 Baird Avantor price target lowered to $43 from $44 at Baird 02/07/22 Barclays Avantor price target raised to $44 from $41 at Barclays 01/27/22 Barclays Avantor price target lowered to $41 from $48 at Barclays AZTA Azenta $86.72 / +0.19 (+0.22%) 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel 11/17/21 Stephens Brooks Automation price target raised to $137 from $130 at Stephens BLFS BioLife Solutions $23.18 / +0.335 (+1.47%) 03/02/22 B. Riley BioLife Solutions price target lowered to $48 from $67 at B. Riley 01/03/22 Stephens Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas 12/31/21 Northland BioLife Solutions named a top pick for 2022 at Northland 10/19/21 B. Riley BioLife Solutions transferred with Buy, $61 target at B. Riley CSTL Castle Biosciences $45.89 / +2.68 (+6.20%) 03/01/22 Lake Street Castle Biosciences price target lowered to $63 from $94 at Lake Street 03/01/22 Baird Castle Biosciences price target lowered to $60 from $82 at Baird 01/06/22 Stephens Stephens starts skin cancer test leader Castle Biosciences at Overweight 01/06/22 Stephens Castle Biosciences initiated with an Overweight at Stephens EBS Emergent BioSolutions $42.52 / +1.03 (+2.48%) 01/20/22 Cantor Fitzgerald Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald 01/20/22 Benchmark Emergent BioSolutions upgraded to Buy from Hold at Benchmark 12/27/21 Cowen Emergent's Narcan sales under immediate threat, says Cowen 11/10/21 Chardan Emergent BioSolutions price target lowered to $75 from $92 at Chardan ENZ Enzo Biochem $3.04 / +0.04 (+1.33%) EVH Evolent Health $31.91 / +0.55 (+1.75%) 03/08/22 Cowen Evolent Health remains top pick after meeting with management, says Cowen 03/07/22 Piper Sandler Evolent Health news removes $82M overhang, says Piper Sandler 03/04/22 Piper Sandler Bright Health expansion big revenue opportunity for Evolent, says Piper 02/24/22 Piper Sandler Evolent Health price target lowered to $32 from $36 at Piper Sandler ICUI ICU Medical $242.89 / -4.85 (-1.96%) 09/09/21 Raymond James ICU Medical price target raised to $286 from $220 at Raymond James INGN Inogen $33.31 / +0.1 (+0.30%) 12/09/21 Needham Inogen upgraded to Buy from Hold at Needham 12/09/21 Needham Inogen upgraded to Buy from Hold at Needham 11/02/21 Fly Intel: Top five analyst upgrades 11/02/21 JPMorgan Inogen upgraded to Neutral with risks priced in at JPMorgan IVC Invacare $1.60 / +0.01 (+0.63%) 09/10/21 Needham Invacare price target lowered to $8 from $17 at Needham 08/19/21 Oppenheimer Invacare initiated with an Outperform at Oppenheimer LMAT LeMaitre $45.32 / +1.54 (+3.52%) 02/25/22 Barrington LeMaitre price target lowered to $54 from $62 at Barrington 09/16/21 Fly Intel: Top five analyst initiations 09/16/21 Jefferies Jefferies starts LeMaitre at Buy on ArteGraft upside potential 09/16/21 Jefferies LeMaitre initiated with a Buy at Jefferies MRVI Maravai Lifesciences $38.84 / +0.34 (+0.88%) 02/28/22 William Blair Maravai buyout price would need to be well into $50s, says William Blair 02/24/22 Baird Maravai Lifesciences price target lowered to $48 from $60 at Baird 10/01/21 Morgan Stanley Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley 08/11/21 Credit Suisse Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse NXGN NextGen Healthcare $20.31 / +0.15 (+0.74%) 01/26/22 Piper Sandler NextGen Healthcare price target raised to $24 from $23 at Piper Sandler 01/06/22 SVB Leerink SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target 01/06/22 SVB Leerink NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink 01/05/22 Piper Sandler NextGen Healthcare named a 2022 top pick at Piper Sandler PINC Premier $35.90 / +0.07 (+0.20%) 11/18/21 Barclays Premier price target raised to $36 from $34 at Barclays 11/03/21 Piper Sandler Premier price target raised to $39 from $31 at Piper Sandler 05/28/21 Fly Intel: Top five analyst downgrades 05/28/21 Barclays Barclays double downgrades Premier with multiple expansion less likely TFX Teleflex $346.65 / -0.61 (-0.18%) 02/24/22 Piper Sandler Teleflex price target raised to $335 from $320 at Piper Sandler 01/21/22 Piper Sandler Teleflex price target lowered to $320 from $325 at Piper Sandler 01/07/22 Morgan Stanley Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution 01/07/22 Morgan Stanley Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley WST West Pharmaceutical $413.43 / +0.93 (+0.23%) XGN Exagen $8.25 / +0.21 (+2.61%) 10/14/21 Cowen Exagen coverage transferred at Cowen 08/10/21 BTIG Exagen price target lowered to $20 from $23 at BTIG 04/15/21 Fly Intel: Top five analyst initiations 04/15/21 Canaccord Canaccord starts Exagen at Buy, sees 50% upside potential XGN WST TFX PINC NXGN MRVI LMAT IVC INGN ICUI EVH ENZ EBS CSTL BLFS AZTA AVTR AVNS ANGO AMWL AGTI XGN Exagen $8.25 / +0.21 (+2.61%) 03/22/22 Exagen sees FY22 revenue $51M-$53M, consensus $56.16M 03/22/22 Exagen reports Q4 EPS (42c), consensus (50c) 11/10/21 Exagen reports Q3 EPS (42c), consensus (46c) WST West Pharmaceutical $413.43 / +0.93 (+0.23%) 02/17/22 West Pharmaceutical sees FY22 EPS $9.20-$9.35, consensus $9.06 02/17/22 West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.91 10/28/21 West Pharmaceutical ups FY21 adjusted EPS view to $8.40-$8.50 from $8.05-$8.20 10/28/21 West Pharmaceutical reports Q3 adjusted EPS $2.06, consensus $1.80 TFX Teleflex $346.65 / -0.61 (-0.18%) 02/24/22 Teleflex sees FY22 adjusted EPS $13.70-$14.30, consensus $14.04 02/24/22 Teleflex reports Q4 adjusted EPS $3.60, consensus $3.53 10/28/21 Teleflex raises 2021 adjusted EPS view to $13.15-$13.35 from $12.90-$13.10 10/28/21 Teleflex reports Q3 adjusted EPS $3.51, consensus $3.03 PINC Premier $35.90 / +0.07 (+0.20%) 02/01/22 Premier lowers FY22 adjusted EPS view to $2.45-$2.55 from $2.56-$2.66 02/01/22 Premier reports Q2 adjusted EPS 73c, consensus 65c 11/02/21 Premier raises FY22 adjusted EPS view to $2.56-$2.66 from $2.50-$2.60 11/02/21 Premier reports Q1 adjusted EPS 64c, consensus 59c NXGN NextGen Healthcare $20.31 / +0.15 (+0.74%) 01/25/22 NextGen Healthcare raises FY22 EPS view to 96c-$1.00 from 90c-96c 01/25/22 NextGen Healthcare reports Q3 adjusted EPS 24c, consensus 21c 10/28/21 NextGen Healthcare raises FY22 EPS view to 90c-96c from 89c-95c 10/28/21 NextGen Healthcare reports Q2 EPS 29c, consensus 23c MRVI Maravai Lifesciences $38.84 / +0.34 (+0.88%) 02/23/22 Maravai Lifesciences sees FY22 revenue $920M-$960M, consensus $863.92M 02/23/22 Maravai Lifesciences reports Q4 EPS 42c, consensus 38c 11/11/21 Maravai Lifesciences sees FY22 revenue $840M-$888M, consensus $789.84M 11/11/21 Maravai Lifesciences sees FY21 adjusted EPS $1.48-$1.52, consensus $1.39 LMAT LeMaitre $45.32 / +1.54 (+3.52%) 02/24/22 LeMaitre reports Q4 EPS 28c, consensus 31c 10/28/21 LeMaitre sees FY21 EPS $1.26-$1.31, consensus $1.35 10/28/21 LeMaitre sees Q4 EPS 29c-34c, consensus 34c 10/28/21 LeMaitre reports Q3 EPS 30c, consensus 32c IVC Invacare $1.60 / +0.01 (+0.63%) 03/08/22 Invacare sees Q1 revenue 'sequentially lower' 03/08/22 Invacare reports Q4 EPS 8c, consensus 2c 10/27/21 Invacare backs FY21 constant currency net sales growth view (1%)-2% 10/27/21 Invacare reports Q3 adjusted EPS (12c), consensus (19c) INGN Inogen $33.31 / +0.1 (+0.30%) 02/24/22 Inogen reports Q4 EPS ($1.01), consensus (73c) 01/10/22 Inogen reports preliminary Q4 revenue $75.9M-$76.9M, consensus $74.6M 11/04/21 Inogen reports Q3 EPS 53c, consensus (26c) ICUI ICU Medical $242.89 / -4.85 (-1.96%) 02/24/22 ICU Medical sees FY22 adjusted EPS $9.00-$10.50, consensus $7.76 02/24/22 ICU Medical reports Q4 EPS 91c, consensus $1.64 11/03/21 ICU Medical reports Q3 EPS $2.07, consensus $1.80 EVH Evolent Health $31.91 / +0.55 (+1.75%) 02/23/22 Evolent Health sees 2022 revenue $1.12B-$1.18B, consensus $1.04B 02/23/22 Evolent Health sees Q1 revenue$280M-$295M, consensus $250.06M 02/23/22 Evolent Health reports Q4 adjusted EPS 8c, consensus 1c 11/03/21 Evolent Health sees Q4 revenue $225M-$240M, consensus $227.18M ENZ Enzo Biochem $3.04 / +0.04 (+1.33%) 10/12/21 Enzo Biochem reports Q4 EPS 7c vs. (7c) last year EBS Emergent BioSolutions $42.52 / +1.03 (+2.48%) 01/09/22 Emergent BioSolutions sees preliminary FY21 revenue $1.78B, consensus $1.7B 11/04/21 Emergent BioSolutions updates FY21 revenue view $1.7B-$1.8B from $1.7B-$1.9B 11/04/21 Emergent BioSolutions reports Q3 adjusted EPS (36c), consensus $2.35 CSTL Castle Biosciences $45.89 / +2.68 (+6.20%) 02/28/22 Castle Biosciences sees FY22 revenue $115M-$120M, consensus $113.54M 02/28/22 Castle Biosciences reports Q4 EPS (25c), consensus (47c) 11/08/21 Castle Biosciences says on track to achieve FY21 revenue of $89M-$93M 11/08/21 Castle Biosciences reports Q3 EPS (47c), consensus (40c) BLFS BioLife Solutions $23.18 / +0.335 (+1.47%) 02/28/22 BioLife Solutions sees FY22 revenue $159.5M-$171.0M, consensus $159.1M 02/28/22 BioLife Solutions reports Q4 EPS (22c), consensus (17c) 01/10/22 BioLife Solutions sees FY21 revenue $119.12M, consensus $116.97M 01/10/22 BioLife Solutions sees Q4 revenue $37.26M, consensus $35.12M AZTA Azenta $86.72 / +0.19 (+0.22%) 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AVTR Avantor $34.73 / +0.245 (+0.71%) 02/03/22 Avantor reports Q4 adjusted EPS 36c, consensus 33c 10/28/21 Avantor reports Q3 adjusted EPS 35c, consensus 32c 10/12/21 Avantor reports preliminary Q3 revenue $1.83B, consensus $1.82B AVNS Avanos $32.46 / +0.51 (+1.60%) 02/23/22 Avanos sees 2022 adjusted EPS $1.55-$1.75, consensus $1.52 02/23/22 Avanos reports Q4 adjusted EPS 46c, consensus 40c 11/02/21 Avanos reports Q3 adjusted EPS 25c, consensus 30c ANGO AngioDynamics $22.71 / -0.44 (-1.90%) 01/06/22 AngioDynamics cuts FY22 adjusted EPS view to (2c)-2c from 0c-5c, consensus 2c 01/06/22 AngioDynamics reports Q2 adjusted EPS (2c), consensus 0c 09/30/21 AngioDynamics sees FY22 EPS 0c-5c, consensus 1c 09/30/21 AngioDynamics reports Q1 EPS (2c), consensus (4c) AMWL Amwell $3.97 / +0.145 (+3.80%) 02/24/22 Amwell sees FY22 revenue $275M-$285M, consensus $312.2M 02/24/22 Amwell reports Q4 EPS (18c), consensus (27c) 11/10/21 Amwell cuts FY21 revenue guidance to $246M-$253M from $252M-$262M 11/10/21 Amwell reports Q3 EPS (20c), consensus (24c) AGTI Agiliti $20.24 / +0.41 (+2.07%) 03/08/22 Agiliti sees FY22 adjusted EPS 89c-94c, consensus 73c 03/08/22 Agiliti reports Q4 adjusted EPS 25c, consensus 9c 11/09/21 Agiliti raises FY21 revenue view to $1.01B-$1.02B from $965M-$980M 11/09/21 Agiliti reports Q3 adjusted EPS 23c, consensus 9c 14 Sep 10 Sep 14 Jul 23 Apr 08 Apr MRVI EVH EBS AMWL MRVI Maravai Lifesciences $38.84 / +0.34 (+0.88%) 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says EVH Evolent Health $31.91 / +0.55 (+1.75%) 09/29/21 Walgreens in talks for potential takeover of Evolent Health, Bloomberg says 09/29/21 Evolent jumps after Bloomberg says Walgreens weighing takeover 09/29/21 Walgreens talks to acquire Evolent Health ongoing, Bloomberg says 09/29/21 Walgreens discussed acquisition of Evolent Health, Bloomberg repots EBS Emergent BioSolutions $42.52 / +1.03 (+2.48%) 10/28/21 Up to 50M doses of J&J vaccine sitting idle in Emergent plant, Reuters reports AMWL Amwell $3.97 / +0.145 (+3.80%) 03/08/22 Lawmakers considering extending telehealth policies, STATNews reports XGN TFX MRVI EVH EBS BLFS AZTA AVTR ANGO AMWL AGTI XGN Exagen $8.25 / +0.21 (+2.61%) 03/22/22 Fly Intel: After-Hours Movers TFX Teleflex $346.65 / -0.61 (-0.18%) 11/03/21 Glaukos, iRhythm soar following updated Medicare reimbursement rates MRVI Maravai Lifesciences $38.84 / +0.34 (+0.88%) 02/25/22 What You Missed On Wall Street On Friday EVH Evolent Health $31.91 / +0.55 (+1.75%) 09/29/21 Wall Street in Fives - Must Read Lists for Wednesday EBS Emergent BioSolutions $42.52 / +1.03 (+2.48%) 11/05/21 Wall Street in Fives - Must Read Lists for Friday 11/05/21 Wall Street in Fives - Must Read Lists at Midday 11/04/21 Fly Intel: After-Hours Movers 10/28/21 Wall Street in Fives - Must Read Lists at Midday BLFS BioLife Solutions $23.18 / +0.335 (+1.47%) 01/18/22 Fly Insider: Landec, AMC Entertainment among week's notable insider trades AZTA Azenta $86.72 / +0.19 (+0.22%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations AVTR Avantor $34.73 / +0.245 (+0.71%) 10/28/21 Fly Intel: After-Hours Movers 10/12/21 Wall Street in Fives - Must Read Lists for Tuesday 10/12/21 Wall Street in Fives - Must Read Lists at Midday 10/12/21 Fly Intel: Pre-market Movers ANGO AngioDynamics $22.71 / -0.44 (-1.90%) 01/12/22 Fly Intel: After-Hours Movers AMWL Amwell $3.97 / +0.145 (+3.80%) 11/11/21 Wall Street in Fives - Must Read Lists for Thursday 11/11/21 Wall Street in Fives - Must Read Lists at Midday AGTI Agiliti $20.24 / +0.41 (+2.07%) 11/29/21 Fly Insider: Asana, Air Lease among week's notable insider trades 03/22/22 Life Sciences & MedTech Virtual Forum 04/07/22 Disruptive Biotech Enabling Technologies Virtual Mini Conference 06/03/22 2022 ASCO Annual Meeting 03/29/22 Amwell - AMWL 04/07/22 AngioDynamics - ANGO 03/24/22 LeMaitre 03/31/22 Enzo Biochem Inc. 04/28/22 Avanos Medical, Inc. 05/12/22 Avantor, Inc. WST IVC ENZ AZTA AMWL WST West Pharmaceutical $413.43 / +0.93 (+0.23%) 11/26/21 Early notable gainers among liquid option names on November 26th 11/16/21 Early notable gainers among liquid option names on November 16th IVC Invacare $1.60 / +0.01 (+0.63%) 10/27/21 Invacare options imply 16.4% move in share price post-earnings ENZ Enzo Biochem $3.04 / +0.04 (+1.33%) 12/15/21 Enzo Biochem options imply 19.8% move in share price post-earnings AZTA Azenta $86.72 / +0.19 (+0.22%) 12/01/21 Thirteen new option listings and one option delisting on December 1st AMWL Amwell $3.97 / +0.145 (+3.80%) 02/24/22 American Well Corp options imply 20.2% move in share price post-earnings
Conference/Events	KeyBanc to hold a virtual forum » 04:55 03/22/22 03/22 04:55 03/22/22 04:55 AGTI Agiliti $19.82 / +0.8 (+4.21%) , AMWL Amwell $3.82 / -0.13 (-3.29%) , ANGO AngioDynamics $23.05 / -0.91 (-3.80%) , AVNS Avanos $32.09 / -0.415 (-1.28%) , AVTR Avantor $34.49 / -0.655 (-1.86%) , AZTA Azenta $86.50 / -0.82 (-0.94%) , BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) , CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) , EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) , ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) , EVH Evolent Health $31.34 / +0.495 (+1.60%) , ICUI ICU Medical $247.68 / +2.9 (+1.18%) , INGN Inogen $33.42 / +0.15 (+0.45%) , IVC Invacare $1.59 / -0.13 (-7.56%) , LMAT LeMaitre $44.15 / -1.91 (-4.15%) , MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) , NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) , PINC Premier $35.85 / -0.51 (-1.40%) , TFX Teleflex $349.16 / -1.02 (-0.29%) , WST West Pharmaceutical $412.49 / -1.72 (-0.42%) , XGN Exagen $8.15 / -0.33 (-3.89%) Life Sciences &… Life Sciences & MedTech Virtual Forum to be held on March 22-23. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XGN WST TFX PINC NXGN MRVI LMAT IVC INGN EVH ENZ EBS CSTL BLFS AZTA AVTR AVNS ANGO XGN Exagen $8.15 / -0.33 (-3.89%) 10/27/21 Exagen expands coverage with Inland Empire Health Plan 10/25/21 Exagen announces $27.2M debt refinancing WST West Pharmaceutical $412.49 / -1.72 (-0.42%) 02/28/22 West Pharmaceutical names Eric Green as Chair of Board 01/25/22 West Pharmaceutical enters supply, technology agreement with Corning TFX Teleflex $349.16 / -1.02 (-0.29%) 02/23/22 Teleflex: FDA clears expanded indication for specialty catheters PINC Premier $35.85 / -0.51 (-1.40%) 03/14/22 Sodexo announces national GPO agreement with Premier 10/26/21 Premier, Resilinc announce supply chain transparency collaboration NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) 12/15/21 NextGen Healthcare CMO Betty Rabinowitz to retire, Robert Murry to succeed 10/28/21 NextGen Healthcare announces $60M share repurchase program 10/05/21 Proxy firms ISS and Glass Lewis support NextGen Healthcare director nominees 09/28/21 NextGen Healthcare provides presentation amid proxy fight against Sheldon Razin MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/25/22 Maravai Lifesciences up 10% after Reuters says rejected $42 per share bid 01/28/22 Maravai Lifesciences acquires MyChem for $240M in cash 12/14/21 Maravai Lifesciences added to the Nasdaq Biotechnology Index 11/29/21 Codex DNA announces commercial availability of BioXp mRNA synthesis kits LMAT LeMaitre $44.15 / -1.91 (-4.15%) 02/24/22 LeMaitre announces $20M share repurchase authorization IVC Invacare $1.59 / -0.13 (-7.56%) 03/08/22 Invacare sees FY22 adjusted EBITDA, free cash fow up from FY21 12/01/21 Invacare realigns EMEA, Asia Pacific businesses 11/30/21 FDA posts warning letter sent to Invacare on November 18 11/05/21 NetScout to replace Invacare in S&P 600 at open on 11/5 INGN Inogen $33.42 / +0.15 (+0.45%) 03/04/22 Inogen names Kristin Caltrider as CFO, succeeding Mike Sergesketter 02/24/22 Inogen sees Q1 revenue similar to Q4, sees FY22 revenue up mid-single digits 12/30/21 Inogen appoints Elizabeth Mora as board chairperson 12/13/21 Inogen announces Sergesketter as Interim Chief Financial Officer EVH Evolent Health $31.34 / +0.495 (+1.60%) 03/07/22 Evolent Health expects to continue provision of services to Cook County Health 02/24/22 Evolent Health rises 16.3% 10/15/21 Evolent Health up 2% as Dealreporter speculates on deal fit with Walgreens 09/29/21 Evolent Health trading resumes ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) 01/03/22 Enzo Biochem appoints CEO Hamid Erfanian to board 10/25/21 Radoff issues letter to Enzo independent directors regarding shareholder unrest 10/21/21 Enzo Biochem expands GoTestMeNow online portal 10/18/21 Enzo Biochem appoints Hamid Erfanian as Chief Executive Officer EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 03/11/22 Emergent BioSolutions initiates Phase 1 study of SIAN 02/18/22 FDA says added four lots of AstraZeneca COVID vaccine acceptable for export 02/11/22 Emergent BioSolutions 'disappointed' in appeals ruling in Narcan case with Teva 01/14/22 Emergent BioSolutions founder and executive chairman, Fuad El-Hibri, to retire CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) 01/12/22 Castle Biosciences publishes sequencing panel study for melanoma analysis 11/24/21 Castle presents data backing clinical utility of DecisionDx portfolio 11/19/21 Castle Biosciences announces publication of DecisionDx-Melanoma data 10/25/21 Castle Biosciences acquiring Pittsburgh Life Science Greenhouse's Cernostics BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 03/18/22 BioLife Solutions receives Nasdaq notice of noncompliance for delayed 10-K 03/17/22 BioLife Solutions announces additional delay in filing Form 10-K 11/04/21 BioLife Solutions names Troy Wichterman as CFO, Roderick de Greef as COO AZTA Azenta $86.50 / -0.82 (-0.94%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AVTR Avantor $34.49 / -0.655 (-1.86%) 02/15/22 Avantor chairman Rajiv Gupta to retire 02/11/22 Avantor starts construction on new distribution center in Ireland 11/15/21 Third Point buys Alight, exits Uber in Q3 09/22/21 Avantor CEO sells 141.3K shares of common stock AVNS Avanos $32.09 / -0.415 (-1.28%) 12/15/21 Avanos announces $30M share repurchase program 12/13/21 Avanos to acquire OrthogenRx, Inc. for $160M ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/12/22 AngioDynamics CEO buys $228K in common stock AGTI AMWL ANGO AVNS AVTR AZTA BLFS CSTL EBS ENZ EVH ICUI INGN IVC LMAT MRVI NXGN PINC TFX WST XGN AGTI Agiliti $19.82 / +0.8 (+4.21%) 03/09/22 Citi Agiliti price target lowered to $25 from $28 at Citi 01/10/22 Citi Agiliti assumed with a Buy at Citi 08/16/21 Citi Citi says Agiliti selloff overdone, boosts target to $22 05/26/21 BMO Capital Agiliti price target raised to $26 from $18 at BMO Capital AMWL Amwell $3.82 / -0.13 (-3.29%) 02/25/22 Piper Sandler Amwell price target lowered to $7 from $12 at Piper Sandler 02/11/22 Goldman Sachs Amwell initiated with a Neutral at Goldman Sachs 12/01/21 Jefferies Amwell initiated with a Hold at Jefferies 11/22/21 Piper Sandler Piper remains buyer of Amwell despite chat supporting below consensus FY22 view ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/07/22 Canaccord AngioDynamics price target lowered to $34 from $37 at Canaccord 10/15/21 Fly Intel: Top five analyst upgrades 10/15/21 Canaccord AngioDynamics upgraded to Buy at Canaccord on future growth clarity 10/15/21 Canaccord AngioDynamics upgraded to Buy from Hold at Canaccord AVNS Avanos $32.09 / -0.415 (-1.28%) 02/24/22 KeyBanc Avanos price target lowered to $41 from $47 at KeyBanc 08/04/21 KeyBanc Avanos price target lowered to $47 from $55 at KeyBanc 08/04/21 Stephens Avanos downgraded to Equal Weight from Overweight at Stephens AVTR Avantor $34.49 / -0.655 (-1.86%) 02/07/22 Raymond James Avantor price target lowered to $43 from $47 at Raymond James 02/07/22 Baird Avantor price target lowered to $43 from $44 at Baird 02/07/22 Barclays Avantor price target raised to $44 from $41 at Barclays 01/27/22 Barclays Avantor price target lowered to $41 from $48 at Barclays AZTA Azenta $86.50 / -0.82 (-0.94%) 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel 11/17/21 Stephens Brooks Automation price target raised to $137 from $130 at Stephens BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 03/02/22 B. Riley BioLife Solutions price target lowered to $48 from $67 at B. Riley 01/03/22 Stephens Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas 12/31/21 Northland BioLife Solutions named a top pick for 2022 at Northland 10/19/21 B. Riley BioLife Solutions transferred with Buy, $61 target at B. Riley CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) 03/01/22 Lake Street Castle Biosciences price target lowered to $63 from $94 at Lake Street 03/01/22 Baird Castle Biosciences price target lowered to $60 from $82 at Baird 01/06/22 Stephens Stephens starts skin cancer test leader Castle Biosciences at Overweight 01/06/22 Stephens Castle Biosciences initiated with an Overweight at Stephens EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 01/20/22 Cantor Fitzgerald Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald 01/20/22 Benchmark Emergent BioSolutions upgraded to Buy from Hold at Benchmark 12/27/21 Cowen Emergent's Narcan sales under immediate threat, says Cowen 11/10/21 Chardan Emergent BioSolutions price target lowered to $75 from $92 at Chardan ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) EVH Evolent Health $31.34 / +0.495 (+1.60%) 03/08/22 Cowen Evolent Health remains top pick after meeting with management, says Cowen 03/07/22 Piper Sandler Evolent Health news removes $82M overhang, says Piper Sandler 03/04/22 Piper Sandler Bright Health expansion big revenue opportunity for Evolent, says Piper 02/24/22 Piper Sandler Evolent Health price target lowered to $32 from $36 at Piper Sandler ICUI ICU Medical $247.68 / +2.9 (+1.18%) 09/09/21 Raymond James ICU Medical price target raised to $286 from $220 at Raymond James INGN Inogen $33.42 / +0.15 (+0.45%) 12/09/21 Needham Inogen upgraded to Buy from Hold at Needham 12/09/21 Needham Inogen upgraded to Buy from Hold at Needham 11/02/21 Fly Intel: Top five analyst upgrades 11/02/21 JPMorgan Inogen upgraded to Neutral with risks priced in at JPMorgan IVC Invacare $1.59 / -0.13 (-7.56%) 09/10/21 Needham Invacare price target lowered to $8 from $17 at Needham 08/19/21 Oppenheimer Invacare initiated with an Outperform at Oppenheimer LMAT LeMaitre $44.15 / -1.91 (-4.15%) 02/25/22 Barrington LeMaitre price target lowered to $54 from $62 at Barrington 09/16/21 Fly Intel: Top five analyst initiations 09/16/21 Jefferies Jefferies starts LeMaitre at Buy on ArteGraft upside potential 09/16/21 Jefferies LeMaitre initiated with a Buy at Jefferies MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/28/22 William Blair Maravai buyout price would need to be well into $50s, says William Blair 02/24/22 Baird Maravai Lifesciences price target lowered to $48 from $60 at Baird 10/01/21 Morgan Stanley Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley 08/11/21 Credit Suisse Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) 01/26/22 Piper Sandler NextGen Healthcare price target raised to $24 from $23 at Piper Sandler 01/06/22 SVB Leerink SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target 01/06/22 SVB Leerink NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink 01/05/22 Piper Sandler NextGen Healthcare named a 2022 top pick at Piper Sandler PINC Premier $35.85 / -0.51 (-1.40%) 11/18/21 Barclays Premier price target raised to $36 from $34 at Barclays 11/03/21 Piper Sandler Premier price target raised to $39 from $31 at Piper Sandler 05/28/21 Fly Intel: Top five analyst downgrades 05/28/21 Barclays Barclays double downgrades Premier with multiple expansion less likely TFX Teleflex $349.16 / -1.02 (-0.29%) 02/24/22 Piper Sandler Teleflex price target raised to $335 from $320 at Piper Sandler 01/21/22 Piper Sandler Teleflex price target lowered to $320 from $325 at Piper Sandler 01/07/22 Morgan Stanley Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution 01/07/22 Morgan Stanley Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley WST West Pharmaceutical $412.49 / -1.72 (-0.42%) XGN Exagen $8.15 / -0.33 (-3.89%) 10/14/21 Cowen Exagen coverage transferred at Cowen 08/10/21 BTIG Exagen price target lowered to $20 from $23 at BTIG 04/15/21 Fly Intel: Top five analyst initiations 04/15/21 Canaccord Canaccord starts Exagen at Buy, sees 50% upside potential XGN WST TFX PINC NXGN MRVI LMAT IVC INGN ICUI EVH ENZ EBS CSTL BLFS AZTA AVTR AVNS ANGO AMWL AGTI XGN Exagen $8.15 / -0.33 (-3.89%) 11/10/21 Exagen reports Q3 EPS (42c), consensus (46c) WST West Pharmaceutical $412.49 / -1.72 (-0.42%) 02/17/22 West Pharmaceutical sees FY22 EPS $9.20-$9.35, consensus $9.06 02/17/22 West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.91 10/28/21 West Pharmaceutical ups FY21 adjusted EPS view to $8.40-$8.50 from $8.05-$8.20 10/28/21 West Pharmaceutical reports Q3 adjusted EPS $2.06, consensus $1.80 TFX Teleflex $349.16 / -1.02 (-0.29%) 02/24/22 Teleflex sees FY22 adjusted EPS $13.70-$14.30, consensus $14.04 02/24/22 Teleflex reports Q4 adjusted EPS $3.60, consensus $3.53 10/28/21 Teleflex raises 2021 adjusted EPS view to $13.15-$13.35 from $12.90-$13.10 10/28/21 Teleflex reports Q3 adjusted EPS $3.51, consensus $3.03 PINC Premier $35.85 / -0.51 (-1.40%) 02/01/22 Premier lowers FY22 adjusted EPS view to $2.45-$2.55 from $2.56-$2.66 02/01/22 Premier reports Q2 adjusted EPS 73c, consensus 65c 11/02/21 Premier raises FY22 adjusted EPS view to $2.56-$2.66 from $2.50-$2.60 11/02/21 Premier reports Q1 adjusted EPS 64c, consensus 59c NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) 01/25/22 NextGen Healthcare raises FY22 EPS view to 96c-$1.00 from 90c-96c 01/25/22 NextGen Healthcare reports Q3 adjusted EPS 24c, consensus 21c 10/28/21 NextGen Healthcare raises FY22 EPS view to 90c-96c from 89c-95c 10/28/21 NextGen Healthcare reports Q2 EPS 29c, consensus 23c MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/23/22 Maravai Lifesciences sees FY22 revenue $920M-$960M, consensus $863.92M 02/23/22 Maravai Lifesciences reports Q4 EPS 42c, consensus 38c 11/11/21 Maravai Lifesciences sees FY22 revenue $840M-$888M, consensus $789.84M 11/11/21 Maravai Lifesciences sees FY21 adjusted EPS $1.48-$1.52, consensus $1.39 LMAT LeMaitre $44.15 / -1.91 (-4.15%) 02/24/22 LeMaitre reports Q4 EPS 28c, consensus 31c 10/28/21 LeMaitre sees FY21 EPS $1.26-$1.31, consensus $1.35 10/28/21 LeMaitre sees Q4 EPS 29c-34c, consensus 34c 10/28/21 LeMaitre reports Q3 EPS 30c, consensus 32c IVC Invacare $1.59 / -0.13 (-7.56%) 03/08/22 Invacare sees Q1 revenue 'sequentially lower' 03/08/22 Invacare reports Q4 EPS 8c, consensus 2c 10/27/21 Invacare backs FY21 constant currency net sales growth view (1%)-2% 10/27/21 Invacare reports Q3 adjusted EPS (12c), consensus (19c) INGN Inogen $33.42 / +0.15 (+0.45%) 02/24/22 Inogen reports Q4 EPS ($1.01), consensus (73c) 01/10/22 Inogen reports preliminary Q4 revenue $75.9M-$76.9M, consensus $74.6M 11/04/21 Inogen reports Q3 EPS 53c, consensus (26c) ICUI ICU Medical $247.68 / +2.9 (+1.18%) 02/24/22 ICU Medical sees FY22 adjusted EPS $9.00-$10.50, consensus $7.76 02/24/22 ICU Medical reports Q4 EPS 91c, consensus $1.64 11/03/21 ICU Medical reports Q3 EPS $2.07, consensus $1.80 EVH Evolent Health $31.34 / +0.495 (+1.60%) 02/23/22 Evolent Health sees 2022 revenue $1.12B-$1.18B, consensus $1.04B 02/23/22 Evolent Health sees Q1 revenue$280M-$295M, consensus $250.06M 02/23/22 Evolent Health reports Q4 adjusted EPS 8c, consensus 1c 11/03/21 Evolent Health sees Q4 revenue $225M-$240M, consensus $227.18M ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) 10/12/21 Enzo Biochem reports Q4 EPS 7c vs. (7c) last year EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 01/09/22 Emergent BioSolutions sees preliminary FY21 revenue $1.78B, consensus $1.7B 11/04/21 Emergent BioSolutions updates FY21 revenue view $1.7B-$1.8B from $1.7B-$1.9B 11/04/21 Emergent BioSolutions reports Q3 adjusted EPS (36c), consensus $2.35 CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) 02/28/22 Castle Biosciences sees FY22 revenue $115M-$120M, consensus $113.54M 02/28/22 Castle Biosciences reports Q4 EPS (25c), consensus (47c) 11/08/21 Castle Biosciences says on track to achieve FY21 revenue of $89M-$93M 11/08/21 Castle Biosciences reports Q3 EPS (47c), consensus (40c) BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 02/28/22 BioLife Solutions sees FY22 revenue $159.5M-$171.0M, consensus $159.1M 02/28/22 BioLife Solutions reports Q4 EPS (22c), consensus (17c) 01/10/22 BioLife Solutions sees FY21 revenue $119.12M, consensus $116.97M 01/10/22 BioLife Solutions sees Q4 revenue $37.26M, consensus $35.12M AZTA Azenta $86.50 / -0.82 (-0.94%) 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AVTR Avantor $34.49 / -0.655 (-1.86%) 02/03/22 Avantor reports Q4 adjusted EPS 36c, consensus 33c 10/28/21 Avantor reports Q3 adjusted EPS 35c, consensus 32c 10/12/21 Avantor reports preliminary Q3 revenue $1.83B, consensus $1.82B AVNS Avanos $32.09 / -0.415 (-1.28%) 02/23/22 Avanos sees 2022 adjusted EPS $1.55-$1.75, consensus $1.52 02/23/22 Avanos reports Q4 adjusted EPS 46c, consensus 40c 11/02/21 Avanos reports Q3 adjusted EPS 25c, consensus 30c ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/06/22 AngioDynamics cuts FY22 adjusted EPS view to (2c)-2c from 0c-5c, consensus 2c 01/06/22 AngioDynamics reports Q2 adjusted EPS (2c), consensus 0c 09/30/21 AngioDynamics sees FY22 EPS 0c-5c, consensus 1c 09/30/21 AngioDynamics reports Q1 EPS (2c), consensus (4c) AMWL Amwell $3.82 / -0.13 (-3.29%) 02/24/22 Amwell sees FY22 revenue $275M-$285M, consensus $312.2M 02/24/22 Amwell reports Q4 EPS (18c), consensus (27c) 11/10/21 Amwell cuts FY21 revenue guidance to $246M-$253M from $252M-$262M 11/10/21 Amwell reports Q3 EPS (20c), consensus (24c) AGTI Agiliti $19.82 / +0.8 (+4.21%) 03/08/22 Agiliti sees FY22 adjusted EPS 89c-94c, consensus 73c 03/08/22 Agiliti reports Q4 adjusted EPS 25c, consensus 9c 11/09/21 Agiliti raises FY21 revenue view to $1.01B-$1.02B from $965M-$980M 11/09/21 Agiliti reports Q3 adjusted EPS 23c, consensus 9c 14 Sep 10 Sep 14 Jul 23 Apr 08 Apr 23 Mar MRVI EVH EBS AMWL MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says EVH Evolent Health $31.34 / +0.495 (+1.60%) 09/29/21 Walgreens in talks for potential takeover of Evolent Health, Bloomberg says 09/29/21 Evolent jumps after Bloomberg says Walgreens weighing takeover 09/29/21 Walgreens talks to acquire Evolent Health ongoing, Bloomberg says 09/29/21 Walgreens discussed acquisition of Evolent Health, Bloomberg repots EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 10/28/21 Up to 50M doses of J&J vaccine sitting idle in Emergent plant, Reuters reports AMWL Amwell $3.82 / -0.13 (-3.29%) 03/08/22 Lawmakers considering extending telehealth policies, STATNews reports TFX MRVI EVH EBS BLFS AZTA AVTR ANGO AMWL AGTI TFX Teleflex $349.16 / -1.02 (-0.29%) 11/03/21 Glaukos, iRhythm soar following updated Medicare reimbursement rates MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/25/22 What You Missed On Wall Street On Friday EVH Evolent Health $31.34 / +0.495 (+1.60%) 09/29/21 Wall Street in Fives - Must Read Lists for Wednesday EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 11/05/21 Wall Street in Fives - Must Read Lists for Friday 11/05/21 Wall Street in Fives - Must Read Lists at Midday 11/04/21 Fly Intel: After-Hours Movers 10/28/21 Wall Street in Fives - Must Read Lists at Midday BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 01/18/22 Fly Insider: Landec, AMC Entertainment among week's notable insider trades AZTA Azenta $86.50 / -0.82 (-0.94%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations AVTR Avantor $34.49 / -0.655 (-1.86%) 10/28/21 Fly Intel: After-Hours Movers 10/12/21 Wall Street in Fives - Must Read Lists for Tuesday 10/12/21 Wall Street in Fives - Must Read Lists at Midday 10/12/21 Fly Intel: Pre-market Movers ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/12/22 Fly Intel: After-Hours Movers AMWL Amwell $3.82 / -0.13 (-3.29%) 11/11/21 Wall Street in Fives - Must Read Lists for Thursday 11/11/21 Wall Street in Fives - Must Read Lists at Midday AGTI Agiliti $19.82 / +0.8 (+4.21%) 11/29/21 Fly Insider: Asana, Air Lease among week's notable insider trades 03/22/22 Life Sciences & MedTech Virtual Forum 04/07/22 Disruptive Biotech Enabling Technologies Virtual Mini Conference 06/03/22 2022 ASCO Annual Meeting 03/22/22 Exagen - XGN 03/29/22 Amwell - AMWL 04/07/22 AngioDynamics - ANGO 03/24/22 LeMaitre 03/31/22 Enzo Biochem Inc. 04/28/22 Avanos Medical, Inc. 05/12/22 Avantor, Inc. WST IVC ENZ AZTA AMWL WST West Pharmaceutical $412.49 / -1.72 (-0.42%) 11/26/21 Early notable gainers among liquid option names on November 26th 11/16/21 Early notable gainers among liquid option names on November 16th IVC Invacare $1.59 / -0.13 (-7.56%) 10/27/21 Invacare options imply 16.4% move in share price post-earnings ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) 12/15/21 Enzo Biochem options imply 19.8% move in share price post-earnings AZTA Azenta $86.50 / -0.82 (-0.94%) 12/01/21 Thirteen new option listings and one option delisting on December 1st AMWL Amwell $3.82 / -0.13 (-3.29%) 02/24/22 American Well Corp options imply 20.2% move in share price post-earnings
Conference/Events	KeyBanc to hold a virtual forum » 17:05 03/21/22 03/21 17:05 03/21/22 17:05 AGTI Agiliti $19.82 / +0.8 (+4.21%) , AMWL Amwell $3.82 / -0.13 (-3.29%) , ANGO AngioDynamics $23.05 / -0.91 (-3.80%) , AVNS Avanos $32.09 / -0.415 (-1.28%) , AVTR Avantor $34.49 / -0.655 (-1.86%) , AZTA Azenta $86.50 / -0.82 (-0.94%) , BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) , CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) , EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) , ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) , EVH Evolent Health $31.34 / +0.495 (+1.60%) , ICUI ICU Medical $247.68 / +2.9 (+1.18%) , INGN Inogen $33.42 / +0.15 (+0.45%) , IVC Invacare $1.59 / -0.13 (-7.56%) , LMAT LeMaitre $44.15 / -1.91 (-4.15%) , MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) , NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) , PINC Premier $35.85 / -0.51 (-1.40%) , TFX Teleflex $349.16 / -1.02 (-0.29%) , WST West Pharmaceutical $412.49 / -1.72 (-0.42%) , XGN Exagen $8.15 / -0.33 (-3.89%) Life Sciences &… Life Sciences & MedTech Virtual Forum to be held on March 22-23. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XGN WST TFX PINC NXGN MRVI LMAT IVC INGN EVH ENZ EBS CSTL BLFS AZTA AVTR AVNS ANGO AMWL XGN Exagen $8.15 / -0.33 (-3.89%) 10/27/21 Exagen expands coverage with Inland Empire Health Plan 10/25/21 Exagen announces $27.2M debt refinancing WST West Pharmaceutical $412.49 / -1.72 (-0.42%) 02/28/22 West Pharmaceutical names Eric Green as Chair of Board 01/25/22 West Pharmaceutical enters supply, technology agreement with Corning TFX Teleflex $349.16 / -1.02 (-0.29%) 02/23/22 Teleflex: FDA clears expanded indication for specialty catheters PINC Premier $35.85 / -0.51 (-1.40%) 03/14/22 Sodexo announces national GPO agreement with Premier 10/26/21 Premier, Resilinc announce supply chain transparency collaboration NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) 12/15/21 NextGen Healthcare CMO Betty Rabinowitz to retire, Robert Murry to succeed 10/28/21 NextGen Healthcare announces $60M share repurchase program 10/05/21 Proxy firms ISS and Glass Lewis support NextGen Healthcare director nominees 09/28/21 NextGen Healthcare provides presentation amid proxy fight against Sheldon Razin MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/25/22 Maravai Lifesciences up 10% after Reuters says rejected $42 per share bid 01/28/22 Maravai Lifesciences acquires MyChem for $240M in cash 12/14/21 Maravai Lifesciences added to the Nasdaq Biotechnology Index 11/29/21 Codex DNA announces commercial availability of BioXp mRNA synthesis kits LMAT LeMaitre $44.15 / -1.91 (-4.15%) 02/24/22 LeMaitre announces $20M share repurchase authorization IVC Invacare $1.59 / -0.13 (-7.56%) 03/08/22 Invacare sees FY22 adjusted EBITDA, free cash fow up from FY21 12/01/21 Invacare realigns EMEA, Asia Pacific businesses 11/30/21 FDA posts warning letter sent to Invacare on November 18 11/05/21 NetScout to replace Invacare in S&P 600 at open on 11/5 INGN Inogen $33.42 / +0.15 (+0.45%) 03/04/22 Inogen names Kristin Caltrider as CFO, succeeding Mike Sergesketter 02/24/22 Inogen sees Q1 revenue similar to Q4, sees FY22 revenue up mid-single digits 12/30/21 Inogen appoints Elizabeth Mora as board chairperson 12/13/21 Inogen announces Sergesketter as Interim Chief Financial Officer EVH Evolent Health $31.34 / +0.495 (+1.60%) 03/07/22 Evolent Health expects to continue provision of services to Cook County Health 02/24/22 Evolent Health rises 16.3% 10/15/21 Evolent Health up 2% as Dealreporter speculates on deal fit with Walgreens 09/29/21 Evolent Health trading resumes ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) 01/03/22 Enzo Biochem appoints CEO Hamid Erfanian to board 10/25/21 Radoff issues letter to Enzo independent directors regarding shareholder unrest 10/21/21 Enzo Biochem expands GoTestMeNow online portal 10/18/21 Enzo Biochem appoints Hamid Erfanian as Chief Executive Officer EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 03/11/22 Emergent BioSolutions initiates Phase 1 study of SIAN 02/18/22 FDA says added four lots of AstraZeneca COVID vaccine acceptable for export 02/11/22 Emergent BioSolutions 'disappointed' in appeals ruling in Narcan case with Teva 01/14/22 Emergent BioSolutions founder and executive chairman, Fuad El-Hibri, to retire CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) 01/12/22 Castle Biosciences publishes sequencing panel study for melanoma analysis 11/24/21 Castle presents data backing clinical utility of DecisionDx portfolio 11/19/21 Castle Biosciences announces publication of DecisionDx-Melanoma data 10/25/21 Castle Biosciences acquiring Pittsburgh Life Science Greenhouse's Cernostics BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 03/18/22 BioLife Solutions receives Nasdaq notice of noncompliance for delayed 10-K 03/17/22 BioLife Solutions announces additional delay in filing Form 10-K 11/04/21 BioLife Solutions names Troy Wichterman as CFO, Roderick de Greef as COO AZTA Azenta $86.50 / -0.82 (-0.94%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AVTR Avantor $34.49 / -0.655 (-1.86%) 02/15/22 Avantor chairman Rajiv Gupta to retire 02/11/22 Avantor starts construction on new distribution center in Ireland 11/15/21 Third Point buys Alight, exits Uber in Q3 09/22/21 Avantor CEO sells 141.3K shares of common stock AVNS Avanos $32.09 / -0.415 (-1.28%) 12/15/21 Avanos announces $30M share repurchase program 12/13/21 Avanos to acquire OrthogenRx, Inc. for $160M ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/12/22 AngioDynamics CEO buys $228K in common stock AMWL Amwell $3.82 / -0.13 (-3.29%) 09/21/21 Amwell appoints Robert Shepardson as CFO AGTI AMWL ANGO AVNS AVTR AZTA BLFS CSTL EBS ENZ EVH ICUI INGN IVC LMAT MRVI NXGN PINC TFX WST XGN AGTI Agiliti $19.82 / +0.8 (+4.21%) 03/09/22 Citi Agiliti price target lowered to $25 from $28 at Citi 01/10/22 Citi Agiliti assumed with a Buy at Citi 08/16/21 Citi Citi says Agiliti selloff overdone, boosts target to $22 05/26/21 BMO Capital Agiliti price target raised to $26 from $18 at BMO Capital AMWL Amwell $3.82 / -0.13 (-3.29%) 02/25/22 Piper Sandler Amwell price target lowered to $7 from $12 at Piper Sandler 02/11/22 Goldman Sachs Amwell initiated with a Neutral at Goldman Sachs 12/01/21 Jefferies Amwell initiated with a Hold at Jefferies 11/22/21 Piper Sandler Piper remains buyer of Amwell despite chat supporting below consensus FY22 view ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/07/22 Canaccord AngioDynamics price target lowered to $34 from $37 at Canaccord 10/15/21 Fly Intel: Top five analyst upgrades 10/15/21 Canaccord AngioDynamics upgraded to Buy at Canaccord on future growth clarity 10/15/21 Canaccord AngioDynamics upgraded to Buy from Hold at Canaccord AVNS Avanos $32.09 / -0.415 (-1.28%) 02/24/22 KeyBanc Avanos price target lowered to $41 from $47 at KeyBanc 08/04/21 KeyBanc Avanos price target lowered to $47 from $55 at KeyBanc 08/04/21 Stephens Avanos downgraded to Equal Weight from Overweight at Stephens AVTR Avantor $34.49 / -0.655 (-1.86%) 02/07/22 Raymond James Avantor price target lowered to $43 from $47 at Raymond James 02/07/22 Baird Avantor price target lowered to $43 from $44 at Baird 02/07/22 Barclays Avantor price target raised to $44 from $41 at Barclays 01/27/22 Barclays Avantor price target lowered to $41 from $48 at Barclays AZTA Azenta $86.50 / -0.82 (-0.94%) 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel 11/17/21 Stephens Brooks Automation price target raised to $137 from $130 at Stephens BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 03/02/22 B. Riley BioLife Solutions price target lowered to $48 from $67 at B. Riley 01/03/22 Stephens Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas 12/31/21 Northland BioLife Solutions named a top pick for 2022 at Northland 10/19/21 B. Riley BioLife Solutions transferred with Buy, $61 target at B. Riley CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) 03/01/22 Lake Street Castle Biosciences price target lowered to $63 from $94 at Lake Street 03/01/22 Baird Castle Biosciences price target lowered to $60 from $82 at Baird 01/06/22 Stephens Stephens starts skin cancer test leader Castle Biosciences at Overweight 01/06/22 Stephens Castle Biosciences initiated with an Overweight at Stephens EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 01/20/22 Cantor Fitzgerald Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald 01/20/22 Benchmark Emergent BioSolutions upgraded to Buy from Hold at Benchmark 12/27/21 Cowen Emergent's Narcan sales under immediate threat, says Cowen 11/10/21 Chardan Emergent BioSolutions price target lowered to $75 from $92 at Chardan ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) EVH Evolent Health $31.34 / +0.495 (+1.60%) 03/08/22 Cowen Evolent Health remains top pick after meeting with management, says Cowen 03/07/22 Piper Sandler Evolent Health news removes $82M overhang, says Piper Sandler 03/04/22 Piper Sandler Bright Health expansion big revenue opportunity for Evolent, says Piper 02/24/22 Piper Sandler Evolent Health price target lowered to $32 from $36 at Piper Sandler ICUI ICU Medical $247.68 / +2.9 (+1.18%) 09/09/21 Raymond James ICU Medical price target raised to $286 from $220 at Raymond James INGN Inogen $33.42 / +0.15 (+0.45%) 12/09/21 Needham Inogen upgraded to Buy from Hold at Needham 12/09/21 Needham Inogen upgraded to Buy from Hold at Needham 11/02/21 Fly Intel: Top five analyst upgrades 11/02/21 JPMorgan Inogen upgraded to Neutral with risks priced in at JPMorgan IVC Invacare $1.59 / -0.13 (-7.56%) 09/10/21 Needham Invacare price target lowered to $8 from $17 at Needham 08/19/21 Oppenheimer Invacare initiated with an Outperform at Oppenheimer LMAT LeMaitre $44.15 / -1.91 (-4.15%) 02/25/22 Barrington LeMaitre price target lowered to $54 from $62 at Barrington 09/16/21 Fly Intel: Top five analyst initiations 09/16/21 Jefferies Jefferies starts LeMaitre at Buy on ArteGraft upside potential 09/16/21 Jefferies LeMaitre initiated with a Buy at Jefferies MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/28/22 William Blair Maravai buyout price would need to be well into $50s, says William Blair 02/24/22 Baird Maravai Lifesciences price target lowered to $48 from $60 at Baird 10/01/21 Morgan Stanley Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley 08/11/21 Credit Suisse Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) 01/26/22 Piper Sandler NextGen Healthcare price target raised to $24 from $23 at Piper Sandler 01/06/22 SVB Leerink SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target 01/06/22 SVB Leerink NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink 01/05/22 Piper Sandler NextGen Healthcare named a 2022 top pick at Piper Sandler PINC Premier $35.85 / -0.51 (-1.40%) 11/18/21 Barclays Premier price target raised to $36 from $34 at Barclays 11/03/21 Piper Sandler Premier price target raised to $39 from $31 at Piper Sandler 05/28/21 Fly Intel: Top five analyst downgrades 05/28/21 Barclays Barclays double downgrades Premier with multiple expansion less likely TFX Teleflex $349.16 / -1.02 (-0.29%) 02/24/22 Piper Sandler Teleflex price target raised to $335 from $320 at Piper Sandler 01/21/22 Piper Sandler Teleflex price target lowered to $320 from $325 at Piper Sandler 01/07/22 Morgan Stanley Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution 01/07/22 Morgan Stanley Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley WST West Pharmaceutical $412.49 / -1.72 (-0.42%) XGN Exagen $8.15 / -0.33 (-3.89%) 10/14/21 Cowen Exagen coverage transferred at Cowen 08/10/21 BTIG Exagen price target lowered to $20 from $23 at BTIG 04/15/21 Fly Intel: Top five analyst initiations 04/15/21 Canaccord Canaccord starts Exagen at Buy, sees 50% upside potential XGN WST TFX PINC NXGN MRVI LMAT IVC INGN ICUI EVH ENZ EBS CSTL BLFS AZTA AVTR AVNS ANGO AMWL AGTI XGN Exagen $8.15 / -0.33 (-3.89%) 11/10/21 Exagen reports Q3 EPS (42c), consensus (46c) WST West Pharmaceutical $412.49 / -1.72 (-0.42%) 02/17/22 West Pharmaceutical sees FY22 EPS $9.20-$9.35, consensus $9.06 02/17/22 West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.91 10/28/21 West Pharmaceutical ups FY21 adjusted EPS view to $8.40-$8.50 from $8.05-$8.20 10/28/21 West Pharmaceutical reports Q3 adjusted EPS $2.06, consensus $1.80 TFX Teleflex $349.16 / -1.02 (-0.29%) 02/24/22 Teleflex sees FY22 adjusted EPS $13.70-$14.30, consensus $14.04 02/24/22 Teleflex reports Q4 adjusted EPS $3.60, consensus $3.53 10/28/21 Teleflex raises 2021 adjusted EPS view to $13.15-$13.35 from $12.90-$13.10 10/28/21 Teleflex reports Q3 adjusted EPS $3.51, consensus $3.03 PINC Premier $35.85 / -0.51 (-1.40%) 02/01/22 Premier lowers FY22 adjusted EPS view to $2.45-$2.55 from $2.56-$2.66 02/01/22 Premier reports Q2 adjusted EPS 73c, consensus 65c 11/02/21 Premier raises FY22 adjusted EPS view to $2.56-$2.66 from $2.50-$2.60 11/02/21 Premier reports Q1 adjusted EPS 64c, consensus 59c NXGN NextGen Healthcare $20.16 / +0.35 (+1.77%) 01/25/22 NextGen Healthcare raises FY22 EPS view to 96c-$1.00 from 90c-96c 01/25/22 NextGen Healthcare reports Q3 adjusted EPS 24c, consensus 21c 10/28/21 NextGen Healthcare raises FY22 EPS view to 90c-96c from 89c-95c 10/28/21 NextGen Healthcare reports Q2 EPS 29c, consensus 23c MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/23/22 Maravai Lifesciences sees FY22 revenue $920M-$960M, consensus $863.92M 02/23/22 Maravai Lifesciences reports Q4 EPS 42c, consensus 38c 11/11/21 Maravai Lifesciences sees FY22 revenue $840M-$888M, consensus $789.84M 11/11/21 Maravai Lifesciences sees FY21 adjusted EPS $1.48-$1.52, consensus $1.39 LMAT LeMaitre $44.15 / -1.91 (-4.15%) 02/24/22 LeMaitre reports Q4 EPS 28c, consensus 31c 10/28/21 LeMaitre sees FY21 EPS $1.26-$1.31, consensus $1.35 10/28/21 LeMaitre sees Q4 EPS 29c-34c, consensus 34c 10/28/21 LeMaitre reports Q3 EPS 30c, consensus 32c IVC Invacare $1.59 / -0.13 (-7.56%) 03/08/22 Invacare sees Q1 revenue 'sequentially lower' 03/08/22 Invacare reports Q4 EPS 8c, consensus 2c 10/27/21 Invacare backs FY21 constant currency net sales growth view (1%)-2% 10/27/21 Invacare reports Q3 adjusted EPS (12c), consensus (19c) INGN Inogen $33.42 / +0.15 (+0.45%) 02/24/22 Inogen reports Q4 EPS ($1.01), consensus (73c) 01/10/22 Inogen reports preliminary Q4 revenue $75.9M-$76.9M, consensus $74.6M 11/04/21 Inogen reports Q3 EPS 53c, consensus (26c) ICUI ICU Medical $247.68 / +2.9 (+1.18%) 02/24/22 ICU Medical sees FY22 adjusted EPS $9.00-$10.50, consensus $7.76 02/24/22 ICU Medical reports Q4 EPS 91c, consensus $1.64 11/03/21 ICU Medical reports Q3 EPS $2.07, consensus $1.80 EVH Evolent Health $31.34 / +0.495 (+1.60%) 02/23/22 Evolent Health sees 2022 revenue $1.12B-$1.18B, consensus $1.04B 02/23/22 Evolent Health sees Q1 revenue$280M-$295M, consensus $250.06M 02/23/22 Evolent Health reports Q4 adjusted EPS 8c, consensus 1c 11/03/21 Evolent Health sees Q4 revenue $225M-$240M, consensus $227.18M ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) 10/12/21 Enzo Biochem reports Q4 EPS 7c vs. (7c) last year EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 01/09/22 Emergent BioSolutions sees preliminary FY21 revenue $1.78B, consensus $1.7B 11/04/21 Emergent BioSolutions updates FY21 revenue view $1.7B-$1.8B from $1.7B-$1.9B 11/04/21 Emergent BioSolutions reports Q3 adjusted EPS (36c), consensus $2.35 CSTL Castle Biosciences $43.62 / -1.41 (-3.13%) 02/28/22 Castle Biosciences sees FY22 revenue $115M-$120M, consensus $113.54M 02/28/22 Castle Biosciences reports Q4 EPS (25c), consensus (47c) 11/08/21 Castle Biosciences says on track to achieve FY21 revenue of $89M-$93M 11/08/21 Castle Biosciences reports Q3 EPS (47c), consensus (40c) BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 02/28/22 BioLife Solutions sees FY22 revenue $159.5M-$171.0M, consensus $159.1M 02/28/22 BioLife Solutions reports Q4 EPS (22c), consensus (17c) 01/10/22 BioLife Solutions sees FY21 revenue $119.12M, consensus $116.97M 01/10/22 BioLife Solutions sees Q4 revenue $37.26M, consensus $35.12M AZTA Azenta $86.50 / -0.82 (-0.94%) 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AVTR Avantor $34.49 / -0.655 (-1.86%) 02/03/22 Avantor reports Q4 adjusted EPS 36c, consensus 33c 10/28/21 Avantor reports Q3 adjusted EPS 35c, consensus 32c 10/12/21 Avantor reports preliminary Q3 revenue $1.83B, consensus $1.82B AVNS Avanos $32.09 / -0.415 (-1.28%) 02/23/22 Avanos sees 2022 adjusted EPS $1.55-$1.75, consensus $1.52 02/23/22 Avanos reports Q4 adjusted EPS 46c, consensus 40c 11/02/21 Avanos reports Q3 adjusted EPS 25c, consensus 30c ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/06/22 AngioDynamics cuts FY22 adjusted EPS view to (2c)-2c from 0c-5c, consensus 2c 01/06/22 AngioDynamics reports Q2 adjusted EPS (2c), consensus 0c 09/30/21 AngioDynamics sees FY22 EPS 0c-5c, consensus 1c 09/30/21 AngioDynamics reports Q1 EPS (2c), consensus (4c) AMWL Amwell $3.82 / -0.13 (-3.29%) 02/24/22 Amwell sees FY22 revenue $275M-$285M, consensus $312.2M 02/24/22 Amwell reports Q4 EPS (18c), consensus (27c) 11/10/21 Amwell cuts FY21 revenue guidance to $246M-$253M from $252M-$262M 11/10/21 Amwell reports Q3 EPS (20c), consensus (24c) AGTI Agiliti $19.82 / +0.8 (+4.21%) 03/08/22 Agiliti sees FY22 adjusted EPS 89c-94c, consensus 73c 03/08/22 Agiliti reports Q4 adjusted EPS 25c, consensus 9c 11/09/21 Agiliti raises FY21 revenue view to $1.01B-$1.02B from $965M-$980M 11/09/21 Agiliti reports Q3 adjusted EPS 23c, consensus 9c 14 Sep 10 Sep 14 Jul 23 Apr 08 Apr 23 Mar MRVI EVH EBS AMWL MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says EVH Evolent Health $31.34 / +0.495 (+1.60%) 09/29/21 Walgreens in talks for potential takeover of Evolent Health, Bloomberg says 09/29/21 Evolent jumps after Bloomberg says Walgreens weighing takeover 09/29/21 Walgreens talks to acquire Evolent Health ongoing, Bloomberg says 09/29/21 Walgreens discussed acquisition of Evolent Health, Bloomberg repots EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 10/28/21 Up to 50M doses of J&J vaccine sitting idle in Emergent plant, Reuters reports AMWL Amwell $3.82 / -0.13 (-3.29%) 03/08/22 Lawmakers considering extending telehealth policies, STATNews reports TFX MRVI EVH EBS BLFS AZTA AVTR ANGO AMWL AGTI TFX Teleflex $349.16 / -1.02 (-0.29%) 11/03/21 Glaukos, iRhythm soar following updated Medicare reimbursement rates MRVI Maravai Lifesciences $38.50 / -2.28 (-5.59%) 02/25/22 What You Missed On Wall Street On Friday EVH Evolent Health $31.34 / +0.495 (+1.60%) 09/29/21 Wall Street in Fives - Must Read Lists for Wednesday EBS Emergent BioSolutions $41.42 / -1.5 (-3.49%) 11/05/21 Wall Street in Fives - Must Read Lists for Friday 11/05/21 Wall Street in Fives - Must Read Lists at Midday 11/04/21 Fly Intel: After-Hours Movers 10/28/21 Wall Street in Fives - Must Read Lists at Midday BLFS BioLife Solutions $22.98 / -1.63 (-6.62%) 01/18/22 Fly Insider: Landec, AMC Entertainment among week's notable insider trades AZTA Azenta $86.50 / -0.82 (-0.94%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations AVTR Avantor $34.49 / -0.655 (-1.86%) 10/28/21 Fly Intel: After-Hours Movers 10/12/21 Wall Street in Fives - Must Read Lists for Tuesday 10/12/21 Wall Street in Fives - Must Read Lists at Midday 10/12/21 Fly Intel: Pre-market Movers ANGO AngioDynamics $23.05 / -0.91 (-3.80%) 01/12/22 Fly Intel: After-Hours Movers AMWL Amwell $3.82 / -0.13 (-3.29%) 11/11/21 Wall Street in Fives - Must Read Lists for Thursday 11/11/21 Wall Street in Fives - Must Read Lists at Midday AGTI Agiliti $19.82 / +0.8 (+4.21%) 11/29/21 Fly Insider: Asana, Air Lease among week's notable insider trades 03/22/22 Life Sciences & MedTech Virtual Forum 04/07/22 Disruptive Biotech Enabling Technologies Virtual Mini Conference 06/03/22 2022 ASCO Annual Meeting 03/22/22 Exagen - XGN 03/29/22 Amwell - AMWL 04/07/22 AngioDynamics - ANGO 03/24/22 LeMaitre 03/31/22 Enzo Biochem Inc. 04/28/22 Avanos Medical, Inc. 05/12/22 Avantor, Inc. WST IVC ENZ AZTA AMWL WST West Pharmaceutical $412.49 / -1.72 (-0.42%) 11/26/21 Early notable gainers among liquid option names on November 26th 11/16/21 Early notable gainers among liquid option names on November 16th IVC Invacare $1.59 / -0.13 (-7.56%) 10/27/21 Invacare options imply 16.4% move in share price post-earnings ENZ Enzo Biochem $3.00 / -0.08 (-2.60%) 12/15/21 Enzo Biochem options imply 19.8% move in share price post-earnings AZTA Azenta $86.50 / -0.82 (-0.94%) 12/01/21 Thirteen new option listings and one option delisting on December 1st AMWL Amwell $3.82 / -0.13 (-3.29%) 02/24/22 American Well Corp options imply 20.2% move in share price post-earnings
On The Fly	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:57 03/21/22 03/21 09:57 03/21/22 09:57 IPG Interpublic Group $36.42 / +0.38 (+1.05%) , DUOL Duolingo $91.17 / +2.09 (+2.35%) , APD Air Products $237.31 / +5.75 (+2.48%) , CBSH Commerce Bancshares $72.22 / +1.17 (+1.65%) , IAS Integral Ad Science $15.47 / +0.905 (+6.21%) , DDL Dingdong $3.78 / +0.05 (+1.34%) , EHTH eHealth $12.85 / -0.39 (-2.95%) , BLND Blend Labs $6.79 / -0.285 (-4.03%) , AVPT AvePoint $5.92 / -0.035 (-0.59%) , AZTA Azenta $87.95 / +0.63 (+0.72%) , SI Silvergate Capital $144.00 / +6.595 (+4.80%) , UGRO Urban-Gro $12.80 / +0.67 (+5.52%) , SPTN SpartanNash $35.44 / +0.685 (+1.97%) , EFSC Enterprise Financial $49.27 / -0.07 (-0.14%) , AMZN Amazon.com $3,237.00 / +8.42 (+0.26%) , CHKP Check Point $136.00 / -4.22 (-3.01%) Institutional investors… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options UGRO SPTN SI IPG IAS EHTH EFSC DUOL DDL CHKP CBSH BLND AZTA AVPT APD AMZN UGRO Urban-Gro $12.80 / +0.67 (+5.52%) 03/14/22 Urban-Gro to acquire Emerald Construction Management for $7M 02/02/22 Urban-Gro announces additional $1.5M expansion of stock repurchase program 01/18/22 Urban-Gro board approves $2M increase to existing stock repurchase program 01/06/22 Urban-Gro named as authorized system integrator for Thrive Agritech SPTN SpartanNash $35.44 / +0.685 (+1.97%) 03/18/22 SpartanNash says priority of activists 'not constructive engagement' 03/17/22 Food solutions company SpartanNash promotes David Sisk to Chief Customer Officer 03/10/22 SpartanNash promotes David Petko to Chief Supply Chain Officer 03/02/22 SpartanNash raises quarterly dividend by 5% to 21c per share SI Silvergate Capital $144.00 / +6.595 (+4.80%) 02/15/22 Silvergate Capital expands Silvergate Exchange Network to include euros 02/09/22 Stronghold Digital, Silvergate, Gannett mentioned as long ideas by Bill Miller 01/31/22 Silvergate acquires blockchain payment network assets from Diem 01/18/22 Silvergate Capital falls -19.2% IPG Interpublic Group $36.42 / +0.38 (+1.05%) 02/10/22 Interpublic increases dividend from 27c to 29c, $400M share repurchase program 01/12/22 Interpublic Group DXTRA CEO Andy Polansky to retire 11/18/21 Interpublic Group executive chairman Michael Roth to retire IAS Integral Ad Science $15.47 / +0.905 (+6.21%) 01/20/22 Integral Ad Science appoints Robert Janecek as CIO 09/28/21 Integral Ad Science announces brand safety solution launch for TikTok video ads EHTH eHealth $12.85 / -0.39 (-2.95%) 03/01/22 eHealth sinks 22% to $12.05 after Q4 results miss estimates 03/01/22 eHealth CEO 'implementing a number of changes' 03/01/22 eHealth plans 'multi-year transformation initiative' 02/28/22 eHealth appoints Roman Rariy as COO, CTO EFSC Enterprise Financial $49.27 / -0.07 (-0.14%) 10/25/21 Enterprise Financial board raised quarterly dividend 5% to 20c per share DUOL Duolingo $91.17 / +2.09 (+2.35%) 02/22/22 Duolingo launches Haitian Creole course 12/14/21 Duolingo appoints John Lilly to board of directors 11/18/21 Duolingo appoints Kendra Ross as head of social impact 11/12/21 Duolingo CEO: We are more of a tech company than a language company DDL Dingdong $3.78 / +0.05 (+1.34%) 03/17/22 Dingdong falls -11.5% 03/16/22 Dingdong rises 53.0% 03/16/22 Dingdong rises 28.6% 03/16/22 Dingdong rises 32.5% CHKP Check Point $136.00 / -4.22 (-3.01%) 03/02/22 Check Point launches unified go-to-market organization 02/01/22 Check Point acquires Spectral, terms not disclosed 01/17/22 Check Point report shows DHL most imitated brand in phishing attempts in Q4 10/28/21 Check Point sees 'very healthy' Q4 CBSH Commerce Bancshares $72.22 / +1.17 (+1.65%) 02/04/22 Commerce Bancshares boosts quarterly dividend 6% to 26.5c 01/19/22 Commerce Bancshares reports Q4 net interest margin 2.43%, down 15 bps from Q3 11/12/21 Commerce Bancshares board approves 5% stock dividend BLND Blend Labs $6.79 / -0.285 (-4.03%) 03/21/22 Blend Labs falls -9.1% 03/08/22 Blend Labs falls -11.3% 11/15/21 Tiger Global boosts stake in Snowflake, exits TAL Education Group 11/11/21 Blend Labs falls -16.7% AZTA Azenta $87.95 / +0.63 (+0.72%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AVPT AvePoint $5.92 / -0.035 (-0.59%) 03/17/22 AvePoint announces $150M share repurchase program 03/10/22 AvePoint launches Entrust product for Microsoft 365 users 03/08/22 AvePoint launches Ransomware Detection 02/22/22 AvePoint enhances global partner program APD Air Products $237.31 / +5.75 (+2.48%) 03/08/22 Air Products to build green liquid hydrogen production facility in Arizona 03/07/22 Air Products, SARGAS to build new ASU at facility in Oman 02/03/22 Air Products raises quarterly dividend 8% to $1.62 from $1.50 per share 12/13/21 Air Products awards Thyssenkrupp contract to supply over 2GW electrolysis plant AMZN Amazon.com $3,237.00 / +8.42 (+0.26%) 03/17/22 Amazon announces that MGM has joined Prime Video and Amazon Studios 03/17/22 Smart for Life products selected by Amazon for launch in Singapore 03/16/22 Senator Elizabeth Warren introduces legislation to limit 'Big Tech' mergers 03/15/22 EU unconditionally approves Amazon acquisition of MGM IPG DUOL APD CBSH IAS DDL EHTH BLND AVPT AZTA SI UGRO SPTN EFSC AMZN CHKP IPG Interpublic Group $36.42 / +0.38 (+1.05%) 03/21/22 Argus Argus upgrades Interpublic Group to Buy amid increased demand, Acxiom benefits 03/21/22 Argus Interpublic Group upgraded to Buy from Hold at Argus 03/14/22 Barclays Interpublic Group downgraded to Equal Weight from Overweight at Barclays 01/27/22 BofA Interpublic Group downgraded to Underperform from Neutral at BofA DUOL Duolingo $91.17 / +2.09 (+2.35%) 03/21/22 KeyBanc KeyBanc upgrades Duolingo to Overweight with $112 price target 03/21/22 KeyBanc Duolingo upgraded to Overweight from Sector Weight at KeyBanc 03/15/22 Evercore ISI Duolingo, XPO Logistics added to 'Best SMID 'Core' Ideas' list at Evercore ISI 03/04/22 Evercore ISI Duolingo removed from 'Tactical Outperform' list, target cut to $120 at Evercore APD Air Products $237.31 / +5.75 (+2.48%) 03/21/22 JPMorgan Air Products upgraded to Overweight from Neutral at JPMorgan 02/08/22 BMO Capital Air Products downgraded to Market Perform from Outperform at BMO Capital 02/07/22 Cowen Air Products price target lowered to $345 from $365 at Cowen 02/07/22 Wells Fargo Air Products price target lowered to $325 from $335 at Wells Fargo CBSH Commerce Bancshares $72.22 / +1.17 (+1.65%) 03/21/22 Wells Fargo Wells Fargo upgrades Commerce Bancshares to Equal Weight, ups target to $70 03/21/22 Wells Fargo Commerce Bancshares upgraded to Equal Weight from Underweight at Wells Fargo 10/11/21 Jefferies Commerce Bancshares price target lowered to $67 from $75 at Jefferies 04/16/21 BofA Commerce Bancshares downgraded to Underperform from Neutral at BofA IAS Integral Ad Science $15.47 / +0.905 (+6.21%) 03/21/22 Raymond James Integral Ad Science upgraded at Raymond James amid 'unjustified' selloff 03/21/22 Raymond James Integral Ad Science upgraded to Strong Buy from Outperform at Raymond James 03/17/22 Barclays Barclays says Meta opening up feed positive for DoubleVerify, Integral Ad 03/04/22 Barclays Integral Ad Science price target lowered to $20 from $23 at Barclays DDL Dingdong $3.78 / +0.05 (+1.34%) 03/21/22 Morgan Stanley Dingdong downgraded to Underweight from Overweight at Morgan Stanley 03/14/22 JPMorgan JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong 03/14/22 JPMorgan Dingdong price target lowered to $2.50 from $21 at JPMorgan 11/19/21 JPMorgan Dingdong initiated with an Underweight at JPMorgan EHTH eHealth $12.85 / -0.39 (-2.95%) 03/21/22 Citi eHealth downgraded to Neutral from Buy at Citi 03/03/22 Credit Suisse eHealth price target lowered to $16 from $31 at Credit Suisse 03/02/22 Craig-Hallum eHealth price target lowered to $15 from $33 at Craig-Hallum 03/02/22 Truist eHealth downgraded to Hold from Buy at Truist BLND Blend Labs $6.79 / -0.285 (-4.03%) 03/21/22 Truist Truist cuts Blend Labs to Hold on lower mortgage applications, stagflation risk 03/21/22 Truist Blend Labs downgraded to Hold from Buy at Truist 02/14/22 Keefe Bruyette Blend Labs initiated with a Market Perform at Keefe Bruyette 01/25/22 KeyBanc Blend Labs price target lowered to $10 from $16 at KeyBanc AVPT AvePoint $5.92 / -0.035 (-0.59%) 03/21/22 Goldman Sachs AvePoint downgraded to Neutral from Buy at Goldman Sachs 01/11/22 Cantor Fitzgerald AvePoint initiated with an Overweight at Cantor Fitzgerald 01/11/22 Cantor Fitzgerald AvePoint initiated with an Overweight at Cantor Fitzgerald 08/16/21 Cowen Cowen starts 'undiscovered' AvePoint with Outperform, $14.50 target AZTA Azenta $87.95 / +0.63 (+0.72%) 03/21/22 Evercore ISI Azenta initiated with an Outperform at Evercore ISI 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel 11/17/21 Stephens Brooks Automation price target raised to $137 from $130 at Stephens SI Silvergate Capital $144.00 / +6.595 (+4.80%) 03/21/22 BofA Silvergate Capital initiated with a Buy at BofA 03/17/22 B. Riley Zions Bancorp downgraded to Neutral on valuation at B. Riley 02/01/22 JPMorgan Silvergate Capital price target lowered to $175 from $200 at JPMorgan 01/26/22 Keefe Bruyette Bloomberg report could weigh on Silvergate shares, says Keefe Bruyette UGRO Urban-Gro $12.80 / +0.67 (+5.52%) 03/21/22 Maxim Urban-Gro initiated with a Buy at Maxim 03/21/22 Maxim Urban-Gro initiated with a Buy at Maxim SPTN SpartanNash $35.44 / +0.685 (+1.97%) 03/21/22 CL King SpartanNash initiated with a Neutral at CL King 11/15/21 Northcoast SpartanNash downgraded to Neutral from Buy at Northcoast 11/12/21 Deutsche Bank SpartanNash price target raised to $24 from $21 at Deutsche Bank EFSC Enterprise Financial $49.27 / -0.07 (-0.14%) 03/21/22 Boenning & Scattergood Enterprise Financial initiated with an Outperform at Boenning & Scattergood AMZN Amazon.com $3,237.00 / +8.42 (+0.26%) 03/16/22 Needham Needham says Netflix needs ads as streamers turn to news, sports 03/15/22 BWS Financial BWS drops coverage of PLx Pharma, says off Amazon again 03/10/22 Deutsche Bank Amazon.com initiated with a Buy at Deutsche Bank CHKP Check Point $136.00 / -4.22 (-3.01%) 03/21/22 Piper Sandler Check Point downgraded to Underweight from Neutral at Piper Sandler 03/17/22 Deutsche Bank Check Point price target raised to $160 from $154 at Deutsche Bank 03/10/22 Cowen Check Point price target raised to $164 from $142 at Cowen 02/16/22 BMO Capital Check Point upgraded to Outperform from Market Perform at BMO Capital UGRO SPTN SI IPG IAS EHTH EFSC DUOL CHKP CBSH BLND AZTA AVPT APD AMZN UGRO Urban-Gro $12.80 / +0.67 (+5.52%) 01/05/22 Urban-Gro sees 2021 revenue $62M, one est. $64.67M. SPTN SpartanNash $35.44 / +0.685 (+1.97%) 02/24/22 SpartanNash sees 2022 adjusted EPS $2.10-$2.25, consensus $1.91 02/24/22 SpartanNash reports Q4 adjusted EPS 18c, consensus 23c 11/10/21 SpartanNash backs FY21 adjusted EPS view $1.70-$1.80, consensus $1.78 11/10/21 SpartanNash reports Q3 adjusted EPS 43c, consensus 41c SI Silvergate Capital $144.00 / +6.595 (+4.80%) 01/18/22 Silvergate Capital reports Q4 EPS 66c, consensus 72c 10/19/21 Silvergate Capital reports Q3 EPS 88c, consensus 71c IPG Interpublic Group $36.42 / +0.38 (+1.05%) 02/10/22 Interpublic Group reports Q4 adjusted EPS 82c, consensus 81c 02/09/22 Notable companies reporting before tomorrow's open 10/21/21 Interpublic Group raises 2021 organic growth view to 11% from 9%-10% IAS Integral Ad Science $15.47 / +0.905 (+6.21%) 03/03/22 Integral Ad Science sees FY22 revenue $416M-$424M, consensus $404.37M 03/03/22 Integral Ad Science sees Q1 revenue $85M-$87M, consensus $84.41M 03/03/22 Integral Ad Science reports Q4 EPS (3c), consensus (1c) 11/10/21 Integral Ad Science sees 2021 revenue $315M-$317M, consensus $309.59M EHTH eHealth $12.85 / -0.39 (-2.95%) 03/01/22 eHealth sees FY22 revenue $448M-$470M, consensus $591.53M 03/01/22 eHealth reports Q4 adjusted EPS 49c, consensus 94c 11/08/21 eHealth lowers FY21 non-GAAP EPS view to (45c)-($1.13) from $$2.77-$3.26 11/08/21 eHealth reports Q3 non-GAAP EPS ($1.78), consensus ($1.02) EFSC Enterprise Financial $49.27 / -0.07 (-0.14%) 01/24/22 Enterprise Financial reports Q4 adjusted EPS $1.23, consensus $1.19 10/25/21 Enterprise Financial reports Q3 adjusted EPS $1.27, consensus $1.00 10/25/21 Enterprise Financial reports Q3 EPS 38c, consensus $1.00 DUOL Duolingo $91.17 / +2.09 (+2.35%) 03/03/22 Duolingo reports Q4 EPS (46c), consensus (68c) 11/10/21 Duolingo sees Q4 revenue $66.5M-$69.5M, consensus $65.65M 11/10/21 Duolingo reports Q3 EPS (98c), consensus (95c) CHKP Check Point $136.00 / -4.22 (-3.01%) 02/03/22 Check Point sees FY22 EPS $6.90-$7.50, consensus $7.34 02/03/22 Check Point sees Q1 EPS $1.48-$1.58, consensus $1.61 02/03/22 Check Point reports Q4 EPS $2.25, consensus $2.12 10/28/21 Check Point sees FY21 EPS $6.81-$7.01, consensus $6.78 CBSH Commerce Bancshares $72.22 / +1.17 (+1.65%) 01/19/22 Commerce Bancshares reports Q4 EPS 94c, consensus 94c 10/19/21 Commerce Bancshares reports Q3 EPS $1.05, consensus 99c BLND Blend Labs $6.79 / -0.285 (-4.03%) 11/10/21 Blend Labs raises FY21 pro forma revenue view to $376M-$386M, consensus $369.75M 11/10/21 Blend Labs reports Q3 GAAP EPS (38c) vs. (38c) a year ago AZTA Azenta $87.95 / +0.63 (+0.72%) 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c AVPT AvePoint $5.92 / -0.035 (-0.59%) 03/17/22 AvePoint sees FY22 revenue $236M-$242M, consensus $254.67M 03/17/22 AvePoint sees Q1 revenue $48M-$49M, consensus $50.53M 03/17/22 AvePoint reports Q4 EPS (4c), consensus 0c 11/15/21 AvePoint sees 2021 revenue $194.4M-$196.4M, consensus $193.89M APD Air Products $237.31 / +5.75 (+2.48%) 02/04/22 Air Products backs FY22 adjusted EPS view $10.20-$10.40, consensus $10.36 02/04/22 Air Products sees Q2 adjusted EPS $2.30-$2.40, consensus $2.52 02/04/22 Air Products reports Q1 adjusted EPS $2.52, consensus $2.51 11/04/21 Air Products sees FY22 adjusted EPS $10.20-$10.40, consensus $10.68 AMZN Amazon.com $3,237.00 / +8.42 (+0.26%) 02/03/22 Amazon sees Q1 revenue $112B-$117B, consensus $120.11B 02/03/22 Amazon reports Q4 EPS $27.75 with gains vs. $14.09 a year ago 02/03/22 Notable companies reporting after market close 11/10/21 Affirm sees fiscal 2022 revenue $1.225B-$1.25B, consensus $1.20B 07 Dec 28 Jul 16 Jul 29 Jun 30 Jun SPTN SI DDL CHKP AMZN SPTN SpartanNash $35.44 / +0.685 (+1.97%) 03/18/22 Activists seek change, potential sale of SpartanNash, Bloomberg reports SI Silvergate Capital $144.00 / +6.595 (+4.80%) 01/26/22 Meta-backed Diem mulling the sale of assets, Bloomberg reports DDL Dingdong $3.78 / +0.05 (+1.34%) 03/16/22 Chinese stocks jump as Beijing vows to keep markets stable, Reuters reports CHKP Check Point $136.00 / -4.22 (-3.01%) 03/14/22 Israeli government sites crash in cyberattack, Haaretz reports AMZN Amazon.com $3,237.00 / +8.42 (+0.26%) 03/20/22 South African court halts construction of Amazon HQ, Reuters reports 03/20/22 Amazon antitrust lawsuit in D.C. dismissed by judge, Bloomberg reports 03/18/22 Amazon sued by the NLRB over labor practices, NY Times reports 03/16/22 Amazon warehouse staff stage walkouts demanding pay raises, Vice reports SPTN SI IPG EHTH DUOL DDL CHKP AVPT APD AMZN SPTN SpartanNash $35.44 / +0.685 (+1.97%) 03/18/22 What You Missed On Wall Street On Friday 03/18/22 What You Missed On Wall Street This Morning SI Silvergate Capital $144.00 / +6.595 (+4.80%) 03/21/22 Fly Intel: Pre-market Movers 02/04/22 Crypto Currents: Silvergate acquires blockchain payment network assets from Diem 02/02/22 #SocialStocks: India grills Big Tech on removing fake news IPG Interpublic Group $36.42 / +0.38 (+1.05%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations EHTH eHealth $12.85 / -0.39 (-2.95%) 11/08/21 Wall Street in Fives - Must Read Lists at Midday DUOL Duolingo $91.17 / +2.09 (+2.35%) 03/04/22 What You Missed On Wall Street On Friday 03/04/22 What You Missed On Wall Street This Morning 03/04/22 Fly Intel: Pre-market Movers DDL Dingdong $3.78 / +0.05 (+1.34%) 03/16/22 What You Missed On Wall Street On Wednesday 03/16/22 What You Missed On Wall Street This Morning CHKP Check Point $136.00 / -4.22 (-3.01%) 01/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/16/21 Microsoft assumption, PayPal initiation among today's top calls on Wall Street AVPT AvePoint $5.92 / -0.035 (-0.59%) 03/17/22 Fly Intel: After-Hours Movers 12/06/21 Fly Insider: Krispy Kreme, Dropbox among week's notable insider trades APD Air Products $237.31 / +5.75 (+2.48%) 02/04/22 Wall Street in Fives - Must Read Lists for Friday 02/04/22 Wall Street in Fives - Must Read Lists at Midday 02/04/22 Fly Intel: Pre-market Movers AMZN Amazon.com $3,237.00 / +8.42 (+0.26%) 03/17/22 What You Missed On Wall Street On Thursday 03/22/22 Life Sciences & MedTech Virtual Forum 03/28/22 Shoptalk 2022 04/07/22 Disruptive Biotech Enabling Technologies Virtual Mini Conference 03/29/22 Urban-Gro - UGRO 03/31/22 Blend Labs - BLND 04/20/22 Commerce Bancshares Inc. 05/25/22 Amazon.com, Inc. SI BLND AZTA AVPT AMZN SI Silvergate Capital $144.00 / +6.595 (+4.80%) 09/24/21 Silvergate Capital Corp call buyer realizes 14% same-day gains BLND Blend Labs $6.79 / -0.285 (-4.03%) 03/21/22 Largest borrow rate increases among liquid names 10/19/21 Three new option listings and eight option delistings on October 19th AZTA Azenta $87.95 / +0.63 (+0.72%) 12/01/21 Thirteen new option listings and one option delisting on December 1st AVPT AvePoint $5.92 / -0.035 (-0.59%) 11/05/21 AvePoint options imply 4.7% move in share price post-earnings 10/06/21 Largest borrow rate increases among liquid names AMZN Amazon.com $3,237.00 / +8.42 (+0.26%) 03/10/22 Early notable gainers among liquid option names on March 10th 02/04/22 Early notable gainers among liquid option names on February 4th 10/18/21 Alibaba plans to launch own cloud server chip, Caixin Global reports
Initiation	Azenta initiated with an Outperform at Evercore ISI » 06:39 03/21/22 03/21 06:39 03/21/22 06:39 AZTA Azenta $87.25 / +2.1 (+2.47%) Evercore ISI analyst… Evercore ISI analyst Vijay Kumar initiated coverage of Azenta with an Outperform rating and $100 price target. With the recent sale of its semi business and the company changing its name to "Azenta" from "Brooks Automation," the company has transitioned from an "industrial/cyclical bent" to pure play life sciences with 100% of its revenues now being life sciences, said Kumar, who sees Azenta offering a "compelling" superior revenue growth outlook with 50% EPS compound annual growth rate potential. ShowHide Related Items >><< Company News Street Research Earnings Events Options AZTA Azenta $87.25 / +2.1 (+2.47%) 01/06/22 Azenta names Matthew McManus as COO 11/16/21 Brooks Automation to change name to Azenta, effective December 1 AZTA Azenta $87.25 / +2.1 (+2.47%) 02/09/22 Needham Azenta price target lowered to $115 from $155 at Needham 11/17/21 Stifel Brooks Automation price target raised to $149 from $134 at Stifel 11/17/21 Stephens Brooks Automation price target raised to $137 from $130 at Stephens AZTA Azenta $87.25 / +2.1 (+2.47%) 02/08/22 Azenta sees Q2 non-GAAP EPS 7c-15c, consensus 11c 02/08/22 Azenta reports Q1 non-GAAP EPS 12c, consensus 8c 03/22/22 Life Sciences & MedTech Virtual Forum 04/07/22 Disruptive Biotech Enabling Technologies Virtual Mini Conference AZTA Azenta $87.25 / +2.1 (+2.47%) 12/01/21 Thirteen new option listings and one option delisting on December 1st

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial